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1. Zusammenfassung 
Sowohl unter homöostatischen Bedingungen als auch während einer 
Entzündung ist die Immunregulation essentiell zum Schutz peripherer 
Gewebe. In dieser Studie untersuchten wir im stationären Zustand und 
während einer akuten Infektion die Rolle Foxp3+ regulatorischer T-Zellen 
(Tregs) und myeloider Suppressorzellen (MDSC), zwei Zellpopulationen mit 
immunregulatorischen Funktionen. Das erste Ziel war es, verschiedene 
Mechanismen zu quantifizieren, die zur Treg-Homöostase in wichtigen 
sekundären lymphatischen Organen beitragen. Dafür wurden in silico 
Modellierung und experimentelle Daten von Treg-Depletion in vivo 
kombinierten und das erste multi-organische mathematische Modell der T-
Zell-Homöostase in Mäusen erstellt. Dies wurde in Kooperation mit Prof. Dr. 
Michael Meyer-Hermann (Abteilung für System-Immunologie, HZI) erreicht. 
Dieser Ansatz offenbarte Unterschiede in der Homöostase von Tregs und 
naïven CD4+ T-Zellen (Tnaïves) in peripheren Lymphknoten (LN) und der 
Milz. So wurde durch das mathematische Model vorhergesagt, dass Treg-
Induktion für die Aufrechterhaltung der Treg-Population in LN relevanter ist 
als in der Milz. Die Ergebnisse führten zu der Schlussfolgerung, dass sich die 
Mechanismen der Treg-Homöostase in LN und der Milz quantitativ 
unterscheiden. Das zweite Ziel war es zu untersuchen, ob andere 
Immunzellpopulationen von der Treg-Depletion in vivo betroffen sind. Dies 
könnte unser Wissen darüber erweitern, wie Tregs das immunologische 
Gleichgewicht im stationären Zustand kontrollieren. Wir haben beobachtet, 
dass sich eine Reihe von Immunzellpopulationen wie dendritische Zellen, 
natürliche Killerzellen und myeloide Zellen in LN und der Milz in Abwesenheit 
von Tregs anhäuft. Interessanterweise unterschieden sich die Kinetik dieser 
Akkumulation in LN und der Milz, was darauf hinweist, dass Immunregulation 
in diesen Organen möglicherweise unterschiedlich erreicht wird. Schließlich 
haben wir die Rolle von MDSC während einer akuten Infektion mit dem 
Influenza-A-Virus (IAV) untersucht. Da es bekannt ist, dass IAV eine starke 
Immunantwort mit folgenden Lungenschäden auslösen kann, könnte dies 
neue Wege enthüllen, die einen Beitrag zur Immunregulation in infizierten 
Lungen leisten. Die Daten der vorliegenden Arbeit zeigten, dass IAV eine 
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Akkumulation von monozytären-MDSC (mono-MDSC) in infizierten Mäusen 
induziert. IAV-induzierte mono-MDSC wiesen die Fähigkeit auf, in vitro die 
Proliferation von 
T-Zellen zu unterdrücken. Der Mechanismus der Unterdrückung war 
abhängig von iNOS, dessen Expression in vivo von IFNγ abhing. Bisher 
wurde davon ausgegangen, dass Monozyten und iNOS eine pro- aber nicht 
eine anti-inflammatorische Rolle nach IAV-Exposition spielen. Die Ergebnisse 
der vorliegenden Arbeit führen somit zu einer Neubewertung der Rolle von 
Monozyten und iNOS während einer IAV-Infektion. Insgesamt hilft diese 
Studie dabei, unser Verständnis zu erweitern, wie Immunregulation durch 
Tregs und MDSC im stationären Zustand und während einer Entzündung 
aufrechterhalten wird. 
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2. Abstract 
Immune regulation is essential to protect peripheral tissues under 
homeostatic conditions as well as during inflammation. In this study, the role 
of forkhead box P3 (Foxp3)-expressing regulatory T cells (Tregs) and 
myeloid-derived suppressor cells (MDSC), two cell populations with immune 
regulatory functions, was investigated in the steady state and in acute 
infection, respectively. The first aim was to quantify different mechanisms 
contributing to Treg homeostasis in major secondary lymphoid organs. 
Thereto, in silico modeling and experimental data from in vivo Treg depletions 
were combined to build the first multi-organ mathematical model of T cell 
homeostasis in mice, which was accomplished in co-operation with Prof. Dr. 
Michael Meyer-Hermann (Department of Systems Immunology, HZI). This 
approach revealed, for example, differences in the homeostasis of Tregs and 
naïve CD4+ T cells (Tnaïves) as well as in their response to Treg depletion 
when comparing their populations in peripheral lymph nodes (LN) and spleen. 
Furthermore, the mathematical model predicted Treg induction to be more 
relevant for maintenance of the Treg population in LN than in the spleen. 
These results led to the conclusion that the mechanisms contributing to Treg 
and Tnaïve homeostasis in LN and spleen quantitatively differ. The second 
aim was to examine whether immune cell subsets other than Tnaïves are 
affected by Treg depletion in vivo. This could expand the knowledge on how 
Tregs maintain immune homeostasis in the steady state. It was observed that 
a range of immune populations, such as dendritic cells (DC), natural killer 
(NK) cells and myeloid cells, accumulate in LN and spleen in the absence of 
Tregs. Interestingly, the kinetics of this accumulation differed in LN and 
spleen, pointing out that immune regulation might be differently achieved in 
these organs. The last aim was to examine the role played by MDSC during 
acute infection with influenza A virus (IAV). Since IAV is known to induce an 
overwhelming immune response associated with lung damage, this could 
unveil new pathways contributing to immune regulation in infected lungs. The 
data demonstrate that IAV induces accumulation of monocytic MDSC (mono-
MDSC) in infected mice. IAV-induced mono-MDSC had the ability to suppress 
T cell proliferation in vitro. The mechanism of suppression applied by mono-
ABSTRACT 
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MDSC was dependent on iNOS expression, the expression of which 
depended on IFNγ in vivo. So far, monocytes and iNOS were believed to play 
a pro- but not an anti-inflammatory role upon IAV challenge. Thus, the results 
of the present study might lead to a reconsideration of the role of monocytes 
and iNOS in IAV infection. Altogether, this study helps to expand the 
understanding of how immune regulation is maintained by Tregs and MDSC 
in the steady state and during inflammation. 
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3. Introduction 
Understanding immune regulation might help intervening in a number of 
diseases, including autoimmunity, cancer, allograft rejection, allergy and 
infection. For example, the importance of immune regulation during infection 
can be observed in the immune response to sepsis and flu, when the immune 
system might overreact and damage own tissues, leading to pathology and 
death. Other examples come from invasion by pathogens able to induce 
immune tolerance, such as observed in viral hepatitis or different parasitic 
infestations. Here, low-levels of effector immune responses allow pathogen 
persistence, which is associated with latent disease and health burden. 
Additionally, studying immune regulation might help the in development of 
strategies to boost vaccination, aiming at improving protection against 
infections at the population levels. Therefore, understanding regulatory 
immune cells, which play are central role in the control of immune responses, 
might open new avenues for the prevention and treatment of a number of 
pathologies. Two subsets of regulatory immune cells able to induce tolerance 
are in the focus of the present study: Tregs and MDSC. Although both are 
known for decades now, many questions regarding their biology have still to 
be addressed, as introduced below. 
 Tregs 3.1.
The vast majority of immune reactions are orchestrated by different CD4+ T 
cell subsets. Among these subsets, Tregs are specialized in 
immunosuppression and are essential for maintenance of immune 
homeostasis and prevention of autoimmunity [1]. Due to promising 
therapeutic applications, such as avoiding autoimmune diseases, promoting 
tolerance towards allografts and as target in cancer immunotherapies [2; 3], 
enormous efforts have been made to comprehensively investigate Treg 
development, homeostasis and function. 
3.1.1. Importance of the transcription factor Foxp3 
Treg function is controlled by the transcription factor Foxp3 [4-6], which was 
first described in 2001 when the association between mutated foxp3 gene 
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and both murine fatal lymphoproliferative disorder and human immune 
dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome was 
discovered [7-9]. Foxp3 expression is of key importance for the 
immunosuppressive phenotype of Tregs [10; 11], and it has been 
demonstrated that epigenetic control of foxp3 and other Treg-associated 
genes leads to the stabilization of the Treg phenotype and to the fixation of 
the Treg lineage [12-15]. Among these genes are, for example, ctla4 
(encoding for cytotoxic T-lymphocyte antigen 4) and il2ra (encoding for the 
high affinity IL-2 receptor α chain, also known as CD25). Indeed, CTLA-4 and 
CD25 play central roles in Treg function. CTLA-4 binds to CD80 and CD86, 
co-stimulatory molecules on the surface of DC, dampening DC interaction 
with effector T cells [16; 17]. CD25 form the high affinity IL-2 receptor in 
combination with CD122 (low affinity IL-2 receptor β chain) and CD132 
(common γ chain). It efficiently binds and consumes IL-2, a survival and 
growth factor for effector T cells [18]. In addition to mediating suppressive 
activity by Tregs, CD25, as part of the IL-2 receptor complex, is central for the 
enhanced IL-2 sensitivity and signaling in Tregs, which is essential for Treg 
homeostasis in the periphery [19; 20]. Foxp3 binds to the IL-2 promoter and 
blocks IL-2 expression in Tregs [21], making them dependent on IL-2 
produced by Tnaïves and creating a Tnaïve/IL-2/Treg feedback control 
mechanism. Therefore, Foxp3 controls Treg function by controlling the 
expression of molecules involved in Treg homeostasis as well as by fine-
tuning the expression of molecules directly involved in Treg-mediated 
suppression. 
3.1.2. Thymic and peripheral development of Tregs 
T cell selection takes place in the thymus, where T cell progenitors carrying a 
newly generated T cell receptor with high affinity for self-antigens are deleted. 
This view has been challenged by the observation that recognition of self-
antigens in the thymus can also induce Foxp3 expression in progenitor T cells 
leading to the development of thymic Tregs (tTregs) [22]. Furthermore, 
Tnaïves circulating in the periphery can, under certain conditions, upregulate 
Foxp3 expression and give rise to peripherally induced Tregs (pTregs). While 
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tTregs are believed to mainly recognize self-antigens, pTregs might 
complement the Treg repertoire by specificities directed against non-
pathogenic foreign antigens, including commensal microbiota and food 
antigens [22-26]. Due to the difference in the nature of antigens recognized 
by tTregs (self) and pTregs (non-self), it is generally considered that these 
populations have different niches and, thereby, different functions [27], 
although this might not be the case under certain conditions [28]. In this 
regard, further studies are necessary before drawing definitive conclusions. 
Estimating the distribution of tTregs versus pTregs within the peripheral Treg 
pool is still a matter to be resolved. Recently, Helios and Neuropilin-1 (Nrp1) 
have been reported as markers to distinguish tTregs and pTregs in vivo in the 
steady state [28-31]. However, both markers can also be upregulated in 
pTregs in the course of T cell activation and differentiation [31; 32]. Further 
investigations on the role of tTregs and pTregs in immune homeostasis are 
necessary, since this could improve the knowledge on immune regulation 
towards self and non-self. 
3.1.3. Diversity and specialized functions of Treg subsets 
Tregs are involved in suppressing both initiation as well as the effector phase 
of an immune response [33]. Accordingly, Tregs were sub-divided into central 
Tregs (cTregs), which recirculate and inhibit T cell priming in secondary 
lymphoid organs, and effector/memory Tregs (eTregs), able to migrate to 
peripheral tissues and inhibit inflammation in situ. Differential expression of 
adhesion molecules and chemokine receptors provides cTregs and eTregs, 
commonly characterized as CD62L+CD44-CCR7+ and CD62L-CD44+CCR7-
CD103+, respectively, proper anatomical localization and corresponding 
suppressive activity [34]. Figure 1 summarizes how Treg homeostasis is 
maintained. In the steady state, tissue-resident eTregs are essential for 
homeostasis of the gut and adipose tissues, for example, which is 
mechanistically achieved, among others, by IL-10 production [35; 36]. Upon 
inflammation, eTregs expand and accumulate, for example, in the skin and 
skeletal muscles, where they play a distinct role in the resolution of the 
immune response [37; 38]. It was discussed that this is accomplished by a 
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CTLA-4-dependent mechanism and by promotion of a switch from pro-
inflammatory to anti-inflammatory myeloid cells, respectively [37; 38]. 
Interestingly, eTregs in skeletal muscle express amphiregulin upon injury and 
can thereby directly promote muscle repair by acting on muscle satellite cells 
[38]. In addition, it is currently a matter of discussion whether the 
transcriptional control of eTregs matches those of T helper subsets. Th1, Th2, 
Th17 and follicular T helper (Tfh) cells are specialized effector T cell subsets 
expressing distinct transcription factors – T-bet, GATA3, RORγt/STAT3 and 
BCL-6, respectively – and orchestrating distinct immune responses. 
Expression of Th-associated transcription factors by Tregs could lead to 
optimal ability to suppress specific Th responses [39]. Lack of T-bet or BCL-6 
in Tregs, for example, prevent expression of the chemokine receptors CXCR3 
and CXCR5, respectively, making Tregs unable to relocate to the 
corresponding anatomical sites where Th1 and Tfh cells are present and 
exerting their functions [40; 41]. Upon arrival at these sites, eTregs 
expressing Th-specific transcription factors upregulate expression of 
suppressor molecules such as IL-10, transforming growth factor-β (TGFβ) 
and granzyme B [40; 41]. The Treg diversity reflects the importance of this 
immune cell subset for maintenance of immune balance in different settings. 
It seems therefore quite surprising that quantitative data on the mechanisms 
leading to a stable Treg population in the periphery, such as thymic output, 
peripheral conversion, activation, proliferation, migration and apoptosis is still 
missing. 
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Figure 1: Treg homeostasis in secondary lymphoid organs. 
Tnaïves and tTregs leave the thymus via the circulation and reach secondary lymphoid 
organs. Tnaïves might encounter DC and either become activated, producing IL-2, or be 
converted into pTregs. Both pTregs and tTregs might become eTregs or cTregs, the survival 
of which depends on DC interaction and Tnaïve-derived IL-2, respectively [34]. Tregs can 
avoid Tnaïve activation by consuming IL-2 and suppressing DC/Tnaïve interactions (not 
depicted). cTregs reenter circulation and survey secondary lymphoid organs, while eTregs 
reenter circulation and survey peripheral tissues. 
3.1.4. Interaction of Tregs with other immune cell subsets 
Besides their role in controlling effector T cells, Tregs were described to 
directly and indirectly regulate other immune cell subsets. DC are considered 
the hub of the immune system. This innate cell type senses signals in the 
environment they are located and migrate towards secondary lymphoid 
organs to initiate and shape the adequate adaptive immune response [42; 
secondary lymphoid organs 
(e.g. LN and spleen) 
circulation (blood/lymph) 
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tTreg 
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43]. In the steady state, the size of the DC population seems to be tightly 
controlled by the size of the Treg population [44; 45]. A loss in Tregs leads to 
a gain in DC, which in turn induces an expansion of Tregs. This feedback 
loop is controlled by Flt3 [44; 45]. NK cells are innate lymphocytes which 
become activated, among others, by IL-2 and are able to limit virus and tumor 
growth before adaptive immunity is mounted [46]. The homeostasis of the NK 
cell population is also modulated by Tregs. Treg-mediated IL-2 consumption 
and inhibition of IL-2 production in Tnaïves play a central role in NK cell 
homeostasis [47-49]. Furthermore, under inflammatory conditions, Tregs can 
suppress effective B cell responses, suppressing antibody production [50-52]. 
Interestingly, although no B cell intrinsic role for Foxp3 was found, B cell 
development is defective in Foxp3-deficient mice [52; 53]. However, since 
these animals suffer from severe multi-organ autoimmune disease, it is 
difficult to distinguish between effects on B cells caused directly by Treg 
absence from those caused by systemic inflammation. Keeping in mind that 
Treg depletion in clinical setting has been proposed as strategy to improve 
immunotherapy and vaccination, it is of central relevance to conclusively 
establish whether and how Tregs regulate homeostasis of other immune cell 
subsets.  
 MDSC 3.2.
As discussed above, Tregs are a constitutive part of the immune system, 
appearing in circulation just some days after birth and controlling the immune 
system throughout life. Differently, MDSC can only be observed under 
inflammatory conditions and were described to appear in cancer, chronic 
inflammation, physical trauma and some infections [54; 55]. Therefore, the 
development of MDSC is currently considered pathological and their 
presence is associated with an ineffective immune response. Much effort has 
been put into characterizing the origin and mechanisms of function of MDSC, 
as they represent potential targets for immunotherapies in the clinics [56]. 
INTRODUCTION 
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3.2.1. Development of monocytes, granulocytes and their 
progenitors into MDSC 
It has become increasingly clear that mono-MDSC arise from 
CD11b+Ly6C++Ly6G- monocytes and monocyte progenitors, which is an 
innate cell lineage developing in the bone marrow and responding to stimuli 
with an impressive plasticity. In the absence of inflammation, Ly6C++ 
monocytes give rise to Nr4a1-dependent Ly6C- monocytes, which are readily 
found within capillaries, surveying endothelial cells and coordinating their 
disposal [57; 58]. For means of simplification and because Ly6C- monocytes 
are far less well described than their Ly6C++ counterpart, the term monocytes 
will be used in this study to refer only to Ly6C++ monocytes. At low levels of 
inflammation, such as in atherosclerosis, some types of cancer and in the 
healthy gut, monocytes can differentiate into tissue-associated macrophages, 
upregulating markers corresponding to the macrophage lineage and 
participating in tissue homeostasis [59-61]. In acute inflammation, such as in 
acute bacterial and viral infections, they can differentiate into professional 
antigen-presenting cells and migrate to the draining LN [62]. At this stage they 
are commonly called “monocyte-derived” (mo-) DC, with the ability to initiate a 
T cell response. Acute inflammation can lead monocytes also to fight infection 
in situ via production of cytokines and effector molecules, such as tumor 
necrosis factor-α (TNFα) and inducible nitric oxide synthase (iNOS), a state in 
which they are called “TNFα/iNOS-producing” (TiP-) DC [63-65].  Both mo-DC 
and TiP-DC have upregulated expression of DC markers. In chronic 
inflammation, such as chronic infection or in cancer, monocytes can acquire 
suppressive activity towards T cells, a state in which they are known as 
mono-MDSC [66]. Interestingly, no markers were found so far with expression 
restricted to mono-MDSC but missing in other monocyte-derived subsets. 
Indeed, until recently, studying MDSC biology by flow cytometry was 
confused as the anti-Gr1 antibody, actually recognizing granulocytes but 
widely used for MDSC studies in the past, binds to two different molecules, 
Ly6C and Ly6G. The use of antibodies able to distinguish Ly6C and Ly6G led 
the way to the description of at least two subsets of MDSC: mono-MDSC 
(CD11b+Ly6C++Ly6G-) and polymorphonuclear MDSC (PMN-MDSC, 
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CD11b+Ly6C+Ly6G+) [66-69]. 
The general assumption that mono-MDSC derive from subverted monocytes 
and their progenitors is mainly due to their similar morphology and expression 
of surface markers. Further indication came from studies of CCR2, a 
chemokine receptor responsible for bone marrow exit of monocytes and, 
thereby, for their accumulation at sites of inflammation [70]. CCR2 deficiency 
leads to a reduction in the accumulation of monocytes and TiP-DC at infection 
sites [63; 64] as well as to a reduction in the number of monocytes and MDSC 
at tumor sites [67; 69]. Also due to similarities in morphology and surface 
markers, PMN-MDSC are thought to arise from subverted granulocytes and 
granulocyte progenitors [55]. However, a recent report described that mono-
MDSC differentiate into PMN-MDSC in tumor-bearing mice as well as in 
cancer patients [71]. According to that model, mono-MDSC acquire Ly6G 
expression as well as granulocyte-like morphology and function, in a process 
regulated by the retinoblastoma gene [71]. Altogether, the similarities of 
monocytes, granulocytes and their progenitors with mono-MDSC and PMN-
MDSC with regard to their morphology, surface markers and response 
towards chemokines as well as the differentiation of mono-MDSC into PMN-
MDSC indicate a complex MDSC developmental pathway. Briefly, MDSC 
development is considered to start under chronic inflammatory conditions with 
monocytes and progenitors giving rise to mono-MDSC, which, together with 
granulocytes and progenitors, further differentiate into PMN-MDSC (Fig. 2). 
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Figure 2: Monocytes and granulocytes during inflammation. 
Granulocyte progenitors (gran prog) and monocyte progenitors (mono prog) differentiate into 
granulocytes (gran) and monocytes (mono) in the bone marrow. During inflammation, they 
travel via the circulation, passing the spleen, while seeking for the inflamed tissue. Upon 
arrival at inflamed tissues, monocytes can further differentiate into tissue-associated 
macrophages (tissue macro), mo-DC and TiP-DC according to microenvironmental clues 
(see main text). Alternatively, monocytes and their progenitors can become mono-MDSC. 
Granulocytes, granulocyte progenitors and mono-MDSC can give rise to PMN-MDSC. MDSC 
can also develop and accumulate in the spleen (not depicted). 
3.2.2. MDSC-mediated suppression and their role in infection 
Among the most studied mechanisms that MDSC apply to modulate an 
immune response is the inhibition of T cells [54]. MDSC can induce nitration 
of tyrosines at the T cell receptor, disrupting antigen recognition and T cell 
activation, they can induce Tregs, which are suppressive by themselves, and 
they can produce anti-inflammatory cytokines such as IL-10 and TGFβ [72-
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76]. Another mechanism of MDSC-mediated T cell suppression involves 
consumption of the semi-essential amino acid arginine by the enzymes iNOS 
and arginase-1 (Arg1), leading to production of reactive nitrogen and oxygen 
species such as nitric oxide (NO), peroxynitrites, superoxide, and hydrogen 
peroxide, which are themselves cytotoxic and inhibitory [54]. Expression of 
indoleamine 2,3-dioxygenase (IDO), which degrades the amino acid 
tryptophan, can also be used by MDSC to perform immunosuppressive 
activity [77; 78]. So far it is not completely understood why some mechanism 
of suppression predominates over others in different inflammatory settings. 
Although MDSC are best known for their role in immune suppression in 
cancer, there are several reports on the development of MDSC during 
infection. In polymicrobial sepsis, for example, MDSC play a protective role by 
dampening excessive inflammation and preventing tissue damage [79]. In 
candidiasis, MDSC are detrimental as they disrupt an effective Th1-mediated 
anti-fungal response [80]. MDSC were also shown to develop during chronic 
infections with human immunodeficiency virus type 1 and lymphocytic 
choriomeningitis virus [81; 82]. However, evidence for MDSC accumulation 
during acute viral infection was only reported for vaccinia virus [83], so that 
their role in other acute viral infections still has to be addressed. 
3.2.3. IAV infection 
Immune regulation is especially important in the context of an acute infection 
of the respiratory tract with IAV, since lethality here is caused by 
inflammation-induced lung destruction [84; 85]. Usually, IAV infection triggers 
mild symptoms such as fever, cough and sore throat. However, the number of 
deaths in a year can substantially incresase if the virus strain circulating in 
that season shows high pathogenicity [86]. For instance, the number of 
deaths in Germany increased by a 60-fold factor, from 300 to 18000, when 
comparing the 2007/08 and the 2008/09 seasons [86]. In addition, the 
disease can become pandemic, which was observed in 1918 with the 
Spanish flu and in 2009 with the swine flu [87; 88]. Challenges with 
vaccination, which respresents the gold standard for protection against IAV, 
come from antigenic drifts and shifts as well as from problems in vaccine 
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production itself [89]. Therefore, it is essential to better comprehend this 
multifaceted, life-threatening and highly pandemic disease. 
IAV belongs to the family of Orthomyxoviridae viruses and, although having 
wild aquatic birds as natural reservoirs, can infect domestic poultry and 
mammals [90]. Its genetic material is encoded in eight segments of negative-
sense RNA, which contain the information for the expression of its eleven 
proteins [91]. Among these proteins, haemagglutinin (HA) and neuraminidase 
(NA), two IAV surface proteins, are categorized into different subtypes, which 
is commonly used for classification of virus strains [90; 91]. For example, if a 
strain carries HA subtype 1 and NA subtype 1, it is classified as H1N1. The 
H7N9 strain spreading in Asia to date and causing human infection and death 
upon exposure to contaminated poultry carries HA subtype 7 and NA subtype 
9 [92]. HA has two functions; on one hand, it recognizes sialic acid on the 
surface of target cells and, on the other, it promotes entry of the virus genome 
into the cell by facilitating fusion of the virus membrane with the endosomal 
membrane [93]. NA enzymatically cleaves sialic acid on the surface of 
infected cells, allowing IAV to be released and to infect new cells [94]. 
Antibodies that bind to HA and NA and block their functions are important for 
protection against new infections. However, HA and NA mutate rapidly in the 
host cell, changing the ability of pre-formed antibodies to bind to them. This 
phenomenon of gradual changes in HA and NA leads to escape from 
acquired immunity and is called antigenic drift [95]. It is also the reason why, 
for optimal protection against emerging infections, the strains used for 
vaccination have to be updated every season [89]. Besides the constant 
mutations causing continuous IAV antigenic drift, the virus can also evolve 
through abrupt, wide-ranging but rare steps known as antigenic shifts [95]. In 
case one cell is infected by two different IAV strains, the genetic material of 
both strains can randomly recombine and a completely new virus can be 
originated. Such reassortment events are believed to have generated the 
novel H7N9 Asian strain [96]. 
Although some IAV strains can infect different species, usually species-
specificity is observed. Important for species-specificity is, among others, the 
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ability of HA to bind to receptors on host cells [97; 98]. HA from different IAV 
strains bind to sialic acid residues with different linkages. For example, HA 
from strains of human origin usually binds to sialic acid residues with a 2-6 
linkage (SA α-2,6) whereas HA from strains of avian origin bind to sialic acid 
residues with a 2-3 linkage (SA α-2,3) [97; 98]. This seems to be an 
adaptation to the differential tissue distribution of sialic acid residues is 
different species. While humans predominantly have SA α-2,6 moieties in the 
respiratory tract, avian species have SA α-2,3 moieties in the gastrointestinal 
tract [97; 98]. Interestingly, mice possess SA α-2,3 moieties in their 
respiratory tract but lack SA α-2,6 moieties, which might explain why human 
IAV strains usually have to be adapted prior to successfully infecting mice 
[99]. Since ferrets resemble humans with regard to tissue distribution of SA α-
2,6 moieties, leading to disease development being highly similar to the 
human infection, they are often used as animal model for IAV studies [100]. 
Despite such disadvantages, use of the murine model of IAV infection vastly 
contributed to understanding of IAV-induced pathology as well as of IAV-
evoked immune response [97; 98]. 
3.2.4. Immune response to IAV and the detrimental role of 
monocytes and their progeny 
Adaptive immunity is essential for the host to fight disease. Plasma cells 
generated during first exposure efficiently produce antibodies that block HA 
and NA from related strains to neutralize the virus [101]. Response by 
memory T cells is also important, as revealed in so-called heterosubtypic 
immunity experiments [102]. Hereto, mice that recovered from a first infection 
are exposed to another strain carrying different HA and NA subtypes (i.e. 
antibodies from the first infection cannot block the second one). Such 
experiments demonstrated that T helper cells and cytotoxic CD8+ T cells 
(CTL) predominantly respond to epitopes from conserved proteins and 
mediate protection of heterosubtypically infected mice [102]. During primary 
infection, both CTL and T helper cells play a determinant role. CTL are 
essential for virus clearance via lysing infected cells in a contact-dependent 
manner, while T helper cells support B cell production of antibodies [103]. 
INTRODUCTION 
 17 
Remarkably, T helper cells were also shown to help CTL production of IL-10 
during primary IAV infection, which was fundamental for mice to keep immune 
balance and avoid lung immunopathology while efficiently clearing the virus 
[104]. Tregs are also involved in the immune response against IAV. During 
primary infection virus antigen-specific Tregs robustly expand in the infected 
lungs whereas during secondary infection they avoid CTL-mediated lung 
inflammation [105; 106]. Therefore, the host developed different strategies to 
fight IAV infection while assuring immune balance in the delicate lung tissues. 
Notably, lethal IAV infection in mice is tremendously attenuated if the number 
of monocytes and TiP-DC in the lungs is experimentally reduced [65; 107]. 
Based on these studies, monocytes and TiP-DC were interpreted as major 
inducers of lung inflammation during IAV infection [108]. In this context, the 
differentiation of lung infiltrating monocytes into MDSC was not considered, 
although some initial studies showed that MDSC might be involved. For 
example, monocytes with anti-inflammatory activity were shown to improve 
the outcome of IAV infection when pre-activated in vivo by Staphylococcus 
aureus products [109]. On the other hand, mice deficient of invariant NK T 
cells and infected with IAV display an overgrowth of MDSC, which impaired a 
proper T cell response to the virus [110]. Therefore, the role of monocyte 
differentiation into mono-MDSC during IAV infection is not clear and should 
be addressed to provide a better understanding of immune regulation in this 
infection. 
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4. Aims 
This thesis consists mainly of two parts. The first focused on Tregs and their 
role in keeping immune homeostasis, whereas the second concentrated on 
the role of MDSC during IAV infection. 
Although Treg homeostasis is of vital importance for mice and men [7-9; 111; 
112], quantitative data on the different processes maintaining Treg stability at 
the population level are only scarcely available. The first part of this study 
aimed at a more refined understanding of Treg homeostasis. Thereto a 
combined in vivo and in silico approach was used to quantify the contribution 
of thymic output, peripheral conversion, migration, proliferation and apoptosis 
of Tregs and Tnaïves to Treg homeostasis in major secondary lymphoid 
organs. 
The role of Tregs in keeping immune homeostasis by modulating the function 
of T cells, DC and NK cells is well established [18; 44; 45; 113]. Less clear is 
the influence of Tregs on other immune cells such as B cells and myeloid 
cells. The next aim here was to analyze the kinetics of different immune 
populations in the absence of Tregs in different secondary lymphoid organs. 
Thereto, the depletion of regulatory T cells (DEREG) mouse model was used, 
which allows for selective ablation of Foxp3+ Tregs in vivo without 
development of severe multi-organ autoimmune disease. Since Treg 
depletion in clinical settings is a major goal of on going translational research, 
it is highly appropriate to examine how Tregs influence homeostasis of other 
cell subsets of the immune system. 
MDSC hamper a proper immune response in cancer and different infections 
[54; 55]. Less well studied is their role during acute viral infection. The second 
part of this work aimed at investigating whether MDSC play a role during IAV 
infection, which is known for the role of monocytes in inducing lung damage 
and enhanced pathology. The murine IAV infection model was used to 
characterize the phenotype of lung mono-MDSC as well as their function and 
kinetics. The mechanistic role of different amino acid cleaving enzymes in 
mono-MDSC-mediated suppression was also examined. Since immune 
regulation by MDSC might have a protective role during acute infections 
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characterized by inflammation-induced tissue destruction, it might be of great 
relevance to study MDSC in the context of IAV infection. 
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5. Material and Methods 
 Material 5.1.
5.1.1. Buffers and Solutions 
PBS/BSA Phosphate-buffered saline (PBS, Invitrogen, Karlsruhe) 
0.2 % BSA (Sigma-Aldrich, Deisenhofen) 
  
ACK buffer Sterile Milli-Q water 
0.01 M KHCO3 (Sigma-Aldrich) 
0.155 M NH4Cl (Sigma-Aldrich) 
0.1 mM Ethylenediaminetetraacetic acid (Roth, Karlsruhe) 
pH 7.5 
  
cRPMI Roswell Park Memorial Institute (RPMI) Medium 1640 - 
GlutaMAX™ (Invitrogen) 
10 % fetal calf serum (FCS; Sigma-Aldrich) 
50 U/ml Penicillin (Biochrom, Berlin) 
50 U/ml Streptomycin (Biochrom) 
25 mM HEPES (Biochrom) 
1 mM Sodium Pyruvate (Biochrom) 
50 µM β-mercaptoethanol (Biochrom) 
  
Digestion buffer Iscove's Modified Dulbecco's Medium (IMDM; Invitrogen) 
10 % fetal calf serum (FCS; Sigma-Aldrich) 
0.2 mg/ml collagenase D (Roche, Mannheim) 
10 mg/ml DNAse (Roche) 
0.8 U/ml Dispase (Roche), added after 30 min of digestion 
5.1.2. Antibodies 
The amount of antibodies needed for each staining was previously defined by 
titration series. 
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Table 1: Antibodies used for flow cytometry. All antibodies were from eBioscience (San 
Diego, CA, USA), BioLegend (San Diego, CA, USA), BD Biosciences (Franklin Lakes, NJ, 
USA), Santa Cruz Biotechnology (Santa Cruz, CA, USA) or R&D Systems (Minneapolis, MN, 
USA). 
Specificity Fluorochrome Clone 
CD3 Biotin, eFluor450, FITC, PE-Cy7, APC 17A2, 
145-2C11 
CD4 Pacific Blue, PerCP-Cy5.5, PE-Cy7, APC, Alexa Fluor 
750 
RM4-5 
CD8 Horizon V500 53-6.7 
CD11b eFluor450, FITC, PE-Cy7, APC-Cy7 M1/70 
CD11c FITC, PerCP-Cy5.5, PE, APC, APC-eFluor780 N418 
CD19 Biotin, APC MB19-1 
CD25 PE-Cy7 PC61.5 
CD44 PerCP-Cy5.5, APC IM7 
CD45R Pacific Blue, PerCP-Cy5.5, PE-Cy7, APC, APC-
eFluor780 
RA3-6B2 
CD49b Biotin, FITC, PE-Cy7, APC DX5 
CD62L FITC MEL-14 
CD69 PE-Cy7 H1.2F3 
CD86 PE GL1 
CD90.2 PE 53-2.1 
CD122 Biotin TM-b1 
CD335 PerCP-Cy5.5, APC 29A1.4 
Foxp3 Alexa Fluor 488, PE, Alexa Fluor 647 FJK-16s 
iNOS Alexa Fluor 647 C-11 
Ly6C eFluor450, Alexa Fluor 488, APC HK1.4 
Ly6G PE-Cy7 1A8 
MHCII FITC, Alexa Fluor 700 M5/114.15.2 
Nrp1 Biotin polyclonal 
Streptavidin PE, PE-Cy7, APC-Cy7 - 
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 Methods 5.2.
5.2.1. Mice 
DEREG mice and wildtype littermates (BALB/c background) were bred at the 
animal facility of the HZI. Eight to twelve weeks old male mice were used. 
C57BL/6 mice for the IAV murine infection model were either bred at the 
animal facility of the HZI or purchased from Janvier (Le Genest-Saint-Isle, 
France). Ten to fourteen weeks old female mice were used here. All animal 
experiments were performed under specific pathogen-free conditions and in 
accordance with institutional, state and federal guidelines. 
5.2.2. DT and Treg depletion 
For Treg depletion in vivo, DEREG mice and wildtype littermates were 
injected by intraperitoneal (i.p.) with 1 µg DT (Merck/Calbiochem, Darmstadt; 
stored at -70 °C until use) diluted in 100 µl sterile PBS (Gibco). DEREG mice 
and wildtype littermates treated with PBS were used as controls (d0). Mice 
were sacrificed at indicated time points and cells from LN and spleen were 
isolated and analyzed. 
5.2.3. Virus preparation and mouse infection 
Mouse-adapted influenza A/Puerto Rico/8/34 (H1N1 PR8) virus strain was 
kindly provided by Prof. Dr. Klaus Schughart and Christin Fricke (Department 
of Infection Genetics, HZI). Intranasal infection was performed with one tenth 
of the median lethal dose (LD50) as defined before for the used virus batch (2 
x 104 focus forming viral units/mouse in 20 µl PBS) [114]. Thereto, mice were 
anesthetized prior to infection by i.p. injection of ketamine, a dissociative 
anesthetic, and xylazine, a sedative/analgesic (10 mg/ml ketamine and 1 
mg/ml xylazine diluted in PBS; 10 µl/g of body weight). Ophthalmic ointment 
was applied to prevent drying of the corneas and mice were kept insulated to 
avoid loss of body heat. Healthy status and body weight were checked every 
second day. Mice losing more than 20 % of body weight within two days were 
euthanized and the infection considered lethal. I.p. injection of 1 mg of either 
anti-IFNγ (R4-6A2) or rat IgG isotype control (HRPN) antibodies from 
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BioXCell (West Lebanon, NH, USA) was performed on day 5 after infection. 
Mice were sacrificed at indicated time points and cells from spleen and lung 
were isolated and analyzed. 
5.2.4. Organ isolation and preparation of single cell suspensions 
Mice were sacrificed by CO2 asphyxia and spleen, LN and/or PBS-perfused 
lungs were taken. Lungs were minced and digested at 37 °C for a total of 45 
min in digestion buffer (see “Buffers and Solutions”). Lung digestion was 
stopped by adding EDTA (ethylenediaminetetraacetic acid) to a final 
concentration of 5 mM and by keeping samples on ice. Single cell 
suspensions were prepared by mechanical squeezing of LN, minced spleens 
or digested lungs through 100 µm nylon meshes. Erythrocytes in spleen and 
lung samples were lysed by incubation with ammonium-chloride-potassium 
(ACK) buffer for 4 minutes at room temperature. Lysis was stopped by diluting 
ACK buffer in a 10-fold volume of PBS/BSA. Centrifugation steps were at 
4 °C and 450 g for 8 minutes. If not described otherwise, samples were 
subsequently maintained in PBS/BSA. 
5.2.5. Cell staining 
Dead cells were stained using LIVE/DEAD® fixable dead cell stain kit 
(Invitrogen), as by the manufacturer. Specific antibody staining was 
performed at 4 °C in the dark for 15 min (surface staining) or 30 min 
(intracellular staining using Foxp3/Transcription Factor Staining Buffer Set 
from eBioscience). LN and spleen were stained in a total volume of 100 µl, 
lung samples in 200 µl. To reduce unspecific antibody binding, surface and 
intracellular staining were performed in the presence of anti-CD16/CD32 
(2.4G2, BioXCell) antibodies and ChromPure rat IgG whole molecule 
(Jackson ImmunoResearch, West Grove, PA, USA), respectively, and using 
pre-determined optimal antibody dilutions. Carboxyfluorescein succinimidyl 
ester (CFSE) staining (10 µM) was performed at 2 x 107 cells/ml of PBS for 2 
min and 45 sec at room temperature. Reaction was stopped by adding a 10-
fold volume of cRPMI (see “Buffers and Solutions”) followed by two 
centrifugation steps in cRPMI. 
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5.2.6. Suppression Assay 
Naïve CD4 T cells were pre-enriched from murine spleens by magnetic 
sorting using anti-CD4 microbeads (Miltenyi, Bergisch Gladbach) labeling 
followed by positive selection using an autoMACS (Miltenyi), as described by 
the manufacturer. Pre-enrichment was followed by fluorescence-activated cell 
sorting (FACS) with the target cells having the phenotype of single 
CD90.2+CD4+CD62LhighCD44-CD25- events. 2 x 105 CFSE-labeled naïve CD4 
T cells were incubated in cRPMI in 96-wells plates for 4 days at 37 °C, >95 % 
humidity and 5 % CO2 in the presence or absence of plate-bound 0.5 µg/ml 
anti-CD3 and 0.1 µg/ml anti-CD28 antibodies (145-2C11 and 37.51, both from 
eBioscience). Mono-MDSC from spleens or digested lungs of IAV-infected 
mice were FACS-sorted as single CD3-CD19-CD49b-CD11b+Ly6C++Ly6G- 
events and added to the cultures at different ratios. 500 µg/ml L-NMMA, 200 
µM 1-MDT (both from Sigma-Aldrich) and 500 µg/ml NOR-NOHA 
(Merck/Calbiochem), were used to block NOS, IDO and arginase, 
respectively. 
5.2.7. Flow cytometry data acquisition 
Data was acquired on either BD LSR II SORP or Fortessa and cells were 
sorted with help of a FACSAria II, all using BD FACSDiva software (all BD 
Biosciences). Data were analyzed by means of FlowJo software (Treestar, 
Ashland, OR, USA). Only single cells were considered for flow cytometry 
analysis. Absolute cell numbers were calculated using a BD Accuri C6 (BD 
Biosciences) flow cytometer according to instructions by the manufacturer. 
5.2.8. Histology 
At day 14 of infection, IAV-infected animals were sacrificed and the lungs 
were excised, gently instilled and subsequently fixed in 4 % buffered formalin 
(pH 7.2). Following sample preparation was performed in the lab of Dr. Silke 
Glage (Experimental Pathology, Hannover Medical School, Hannover). After 
trimming according to the Registry of Industrial Toxicology Animal-data 
recommendations [115], and dehydration (Shandon Hypercenter, XP), the 
lungs were embedded in paraffin. Sections were deparaffinized with xylene 
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and H&E stained to evaluate general morphology by light microscopy 
(Axioskop 40; Zeiss, Jena). Dr. Silke Glage used a blinded, semi-quantitative 
scoring-system to grade the pathologic changes in the lungs, as described 
previously [116]. 
5.2.9. Enzyme-linked immunosorbent assay (ELISA) 
The mouse IFNγ ELISA MAX Deluxe kit was purchased from BioLegend. 
Measurements were performed as described by the manufacturer. Briefly, 
lungs were isolated and stored in 1 ml sterile PBS at -70 °C until 
homogenized. For homogenization, samples were thawed, diluted in 4 ml 
sterile PBS containing cOmpleteTM Protease Inhibitor Cocktail from Millipore 
(used as described by manufacturer) and processed using a Polytron 
PT1200C homogenizer (Kinematica, Lucerne, Switzerland). After a 
centrifugation step for 10 minutes at 1000 g and 4 °C, supernatants were 
stored at -70 °C until measurement. 
5.2.10. Statistics 
The following calculation of p-values was performed by Prof. Dr. Frank 
Klawonn (Department of Bioinformatics and Statistics, HZI) and applied to the 
comparison of the effect of DT treatment on different immune cell subsets in 
wildtype and DEREG mice. Log2 Laplace corrected values were considered, 
i.e. 1 was added to each of the original values and then the logarithm was 
calculated. The Laplace correction was necessary because there are zero 
values for which the logarithm is not defined. Under the assumption that the 
wildtype values followed roughly the same distribution over the whole period 
of time, the wildtype values were taken as an empirical distribution (most of 
the wild type value distributions did not resemble a normal distribution). The 
smallest value of the available DEREG values at time point t was considered. 
When there are n DEREG values available at time point t, the p-value is the 
probability that a random sample of size n from the wildtype values over the 
whole time period contains only values greater than or equal to the minimum 
of the considered DEREG values. Using GraphPad Prism software (La Jolla, 
CA, USA), one tailed, Mann-Whitney test was applied to calculate the p-value 
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when comparing iNOS expression by lung mono-MDSC in mice infected with 
IAV and either injected with IgG control or anti-IFNγ antibody. * = p < 0.05. 
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6. Results 
 Tregs and their role in keeping immune homeostasis 6.1.
6.1.1. LN and spleen exhibit differences in T cell subset composition 
in the steady state as well as after Treg depletion 
In order to investigate the mechanisms contributing to Treg homeostasis in 
the steady state, the ratio of Tregs to Tnaïves in LN (pool of inguinal, brachial, 
axillary, submandibular and cervical LN) and spleen of healthy adult mice was 
assessed. The ratio of Tregs to Tnaïves was higher in spleen than in LN (Fig. 
3A ”homeostasis”). T cell homeostasis requires survival factors such as weak 
T cell receptor engagement and signaling by cytokines like IL-2 and IL-7. 
Such ”tonic” signals lead to T cell proliferation without causing full T cell 
activation and differentiation [117]. The early activation marker CD69 was 
analyzed here to identify such proliferating T cells and the term activated T 
cells will be used for this particular CD69+ T cell subset throughout this study. 
The percentages of CD69+ Tregs and Tnaïves were found to be higher in LN 
than in spleen (Fig. 3A “homeostasis”, blue rectangles). Next, DEREG mice 
were used to monitor T cell dynamics after Treg depletion. DEREG mice carry 
a bacterial artificial chromosome encoding a fusion protein of diphtheria toxin 
(DT) receptor and enhanced green fluorescent protein under control of the 
foxp3 gene regulatory elements, allowing selective Foxp3+ Treg ablation in 
vivo via DT injection [111]. An almost complete depletion of Tregs was 
achieved two days after a single DT administration (Fig. 3A “d2”). The Treg 
rebound as well as CD69 expression on T cell subsets were analyzed in LN 
and spleen on days two, seven and 21 after DT injection (Fig. 3A). The 
fraction of CD69+ Tnaïves was increased in comparison to homeostatic 
conditions and remained elevated, particularly in the spleen, at least until day 
21 (Fig. 3A, blue rectangles). Surprisingly, the total Tnaïve population 
expanded in LN but shrunk in spleen within two days after DT application 
(Fig. 3B). Interestingly, the Treg population exhibited a pronounced overshoot 
in both organs on day seven after DT (Fig. 3B). In summary, LN and spleen 
show organ-specific ratios of Tregs to Tnaïves under homeostatic conditions 
as well as organ-specific Tnaïve dynamics after Treg depletion. 
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Figure 3: LN and spleen exhibit differences in T cell subset composition in the steady 
state as well as after Treg depletion. 
A: In left panels are zebra plots representing total Tregs (Foxp3+, black rectangles), CD69+ 
Tregs (red rectangles) and CD69+ Tnaïves (blue rectangles) in LN or spleen in homeostasis. 
Plots are gated on CD3+CD4+ live singlets. Percentages of Tregs and Tnaïves were 
calculated among all Tregs and all Tnaïves, respectively, and represent mean values for 14 
animals. Other panels show the corresponding data on days two, seven and 21 after DT 
injection in DEREG mice. Representative data are depicted. B: Data on fold change in the 
mean absolute numbers of total Tnaïves and Tregs on respective days after DT treatment are 
shown in comparison to PBS-treated DEREG mice (dotted line). Data were pooled from at 
least two independent experiments (n ≥ 4 for each time point). 
6.1.2. A multi-organ mathematical model of T cell homeostasis 
The differences observed between LN and spleen in Treg homeostasis and 
Tnaïve dynamics after Treg depletion might be due to different contributions 
of homeostatic mechanisms to Treg reconstitution in both organs. To answer 
this question, the in vivo data described above were analyzed with the help of 
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a specifically designed mathematical model, which was created in co-
operation with Prof. Dr. Michael Meyer-Hermann. LN and spleen were 
modeled as separated entities and recirculation between them was included. 
This led to the first multi-organ mathematical model for Treg homeostasis and 
Tnaïve recirculation in mice (Fig. 4). The model incorporates thymic output, 
apoptosis and proliferation of Tnaïves and Tregs, as well as conversion of 
Tnaïves to pTregs, allowing the determination of the relative contribution of 
these different mechanisms to Treg homeostasis. The most important 
assumptions of the model are: 
• Considered organs are thymus, LN, and spleen. LN and spleen embed 
each Tnaïves and Tregs, both of which can be in a resting or activated 
state.  
• Cells behave according to the same mechanisms in LN and spleen. 
The organ-specific environment is reflected in the differences in the 
steady state populations.  
• Homeostatic division of Tnaïves is controlled by Tregs through 
competition for survival factors such as antigen presenting cells, IL-2 
and IL-7 [118-120]. 
• Homeostatic division of Tregs specifically depends on IL-2 provided by 
homeostatically dividing Tnaïves [121; 122]. 
• Resting Tnaïves and Tregs migrate between both organs. Migration 
dynamics are organ-specific, but not T cell subset-specific.  
• Mechanisms potentially contributing to Treg reconstitution after 
depletion are dynamic thymic output, Treg division, and conversion of 
Tnaïves to Tregs. 
• For reasons of simplification, Treg subsets were not considered. 
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Figure 4: A multi-organ mathematical model of T cell homeostasis. 
The thymus generates Tnaïves and Tregs, which both distribute to LN and spleen. Tnaïves 
and Tregs can undergo apoptosis, become activated and divide, as well as return to the 
resting state in both organs. Activated Tregs modulate Tnaïve activation, while activated 
Tnaïves modulate Treg activation. Activated Tnaïves can convert into Tregs. Resting T cells 
migrate between both organs. 
6.1.3. The mathematical model describes Treg reconstitution and 
Tnaïve dynamics after Treg depletion 
The evident question was whether the model could describe the organ-
specific differences observed after Treg depletion. As data with high temporal 
resolution improve the accuracy of parameter prediction, additional 
experimental Treg depletions were performed. The following time points were 
included: every six hours until day two, daily until day eight and on days 10, 
14, 21 and 60. PBS-treated DEREG mice were taken as baseline. After the 
fitting routine using a differential evolution algorithm, which was performed by 
Prof. Dr. Michael Meyer-Hermann, the mathematical model was able to 
simultaneously describe the measured Treg reconstitution and Tnaïve 
dynamics in LN and spleen after Treg depletion (Fig. 5). Interestingly, the 
overshoot of Tregs observed in vivo was also reproduced in silico (Fig. 5A 
and B). The quantitative differences in the measured homeostatic populations 
(Fig. 3A “homeostasis”) turned out to be sufficient to reflect the specificities of 
LN and spleen. Thus, the qualitatively different behavior in LN and spleen did 
not require a differentiation of mechanisms between organs. However, for the 
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mathematical model to describe the in vivo data, it was required to assume 
that Tnaïves dynamically recirculate between the organs as well as that 
emigration of Tnaïves from LN or spleen is suppressed by the local presence 
of Tregs. In the model it was assumed that the motility of Tnaïves depends on 
the ratio of Tregs to Tnaïves. While the exact structure of this dependency 
was not compulsory, an impact of Tregs onto Tnaïve motility was required in 
order to reproduce the dynamics of Treg reconstitution. In particular, this was 
the only identified explanation for the reduction of total T cell numbers in 
spleen which was accompanied by an increase of total T cell numbers in LN. 
 
Figure 5: The mathematical model describes Treg reconstitution and Tnaïve dynamics 
after Treg depletion. 
Depletion of Tregs by DT administration (at time zero) and dynamics of reconstitution of the 
indicated T cell populations are shown in DEREG mice (symbols) and in silico (lines). 
Absolute T cell numbers are shown for LN and spleen. In vivo data are pooled from at least 
two independent experiments as well as two to four animals per time point. In silico 
parameter values were derived from steady state conditions as well as from independent 
experimental constraints. A best fit of unknown parameters to the in vivo data was generated 
with the help of a differential evolution algorithm. 
6.1.4. Blockade of protein synthesis leads to rapid downregulation of 
CD122 in Tregs 
The high affinity IL-2 receptor, which plays a fundamental role in keeping 
peripheral Treg homeostasis [19; 20], is composed of three subunits: CD25, 
CD122 and CD132. CD122 is important for the IL-2/CD25 dimeric complex to 
interact with CD132 as well as for signal transduction [123]. Therefore, the 
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expression of CD122 by Tregs was followed in the depletion experiments with 
high temporal resolution described above. Virtually all Tregs in both LN and 
spleen expressed CD122 in the steady state (Fig. 8, “PBS”, data from LN are 
shown). Surprisingly, although the number of Tregs found in LN and spleen 
only started to decrease 18 hours after DT application into DEREG mice (Fig. 
5), a substantial downregulation of CD122 from the surface of Tregs was 
observed already six hours after treatment (Fig. 6). In other words, although 
Tregs were still physically present in LN and spleen in the first hours after 
treatment, DT, which acts in eukaryotic cells unsettling protein synthesis, had 
already started disrupting Treg homeostasis at the cellular level. Tregs 
showed normal expression of CD122 during rebound at later time points (data 
not shown). 
 
Figure 6: Blockade of protein synthesis leads to rapid downregulation of CD122 in 
Tregs. 
Zebra plots show expression of CD122 and Foxp3 in gated CD3+CD4+ single events from LN 
of DEREG mice after treatment with PBS or DT at indicated time points. Balloons represent 
gates and numbers are percentages of cells within gates. Representative data from two 
experiments each with two mice per time point are shown. 
6.1.5. Recirculation of Tregs is decreased when compared to 
Tnaïves  
The model allows for T cell recirculation of both Tnaïves and Tregs, whereby 
the migration of Tregs is controlled by the parameter χR. For χR = 1, Tregs 
and Tnaïves recirculate at the same rates. The existence of a steady state 
solution based on the measured T cell subsets in the resting state imposes χR 
< 0.25. Thus, the model predicts that recirculation of Tregs is reduced in 
Foxp3 
CD122 
PBS 6 hours 18 hours 48 hours 
time upon DT injection 
10.8 
0.4 
6.2 
5.1 
0.4 
7.1 
0.6 
0.1 
RESULTS 
 33 
comparison to Tnaïves. When χR was included in the parameter fitting 
routine, the differential evolution algorithm determined a value of χR = 0.0036. 
As this value was very small, only the results where recirculation of Tregs was 
neglected are presented. However, all results were repeated with χR = 0.2 
and the quality of the best fit was the same as without Treg recirculation and 
the statements derived from the model remained unaltered (data no shown). 
However, recirculation of T cells became asymmetric, as cells only migrated 
from spleen to LN but not back and the steady state frequency of trans-organ 
migration was very low, in contradiction to measured organ transition times of 
T cells [124-126]. This result indicates that, in comparison to Tnaïves, Tregs 
recirculate at a much lower rate. 
6.1.6. Conversion added an important contribution to Treg 
homeostasis, especially in LN 
Conversion of Tnaïves to pTregs is considered an essential process for 
complementation of the Treg repertoire towards recognition and tolerance of 
non-self antigens. It was therefore of interest to estimate the rate of peripheral 
Treg conversion in vivo. Using another mouse strain in which it is also 
possible to deplete Tregs by DT injection, Suffner et al. described that 
proliferation of Tregs is the dominant path of Treg reconstitution [127]. 
Although the results here are in agreement with that (Fig. 7, red lines), the 
present analysis went beyond and asked to which extent conversion of 
Tnaïves into pTregs happens and which role it plays in Treg reconstitution 
after depletion. Indeed, very high levels of conversion following Treg depletion 
were found (Fig. 7A and B, green lines), ranging from 1 x 105 pTregs 
appearing per day in spleen to 2 x 105 in LN, at the peak of conversion. Even 
more importantly, conversion peaked in both organs at day two after DT 
injection, while Treg proliferation peaked one to two days later (Fig. 7A and B, 
red lines). These results suggest that conversion of Tnaïves into pTregs 
triggers reconstitution of the Treg population. Indeed, without this early 
conversion, the Treg population would not acquire the critical mass enabling a 
fast rebound of Tregs within three days after their disappearance following DT 
treatment. 
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The next question was whether conversion plays a relevant role also in Treg 
homeostasis under steady state conditions. In the resting state, maintenance 
of LN Tregs equally depended on conversion, thymic output and proliferation 
(Fig. 7A, compare green, black and red lines at time points before zero), 
whereas conversion had a lower contribution to splenic Tregs in comparison 
to thymic output and proliferation (Fig. 7B). According to the model, around 
2400 and 760 converted pTregs appeared per day in LN and spleen in the 
steady state, respectively. 
 
Figure 7: Conversion added an important contribution to Treg homeostasis, especially 
in LN. 
The contributions to the reconstitution of the Treg population after depletion are shown in LN 
and spleen: thymic output (black line), Treg division (red line) and conversion from Tnaïve to 
Treg (green line) as well as of cell death (dotted blue line, multiplied with 1 for comparison). 
The respective contributions correspond to the terms contributing to total Treg compartments. 
 
If there is a higher conversion rate in LN compared to spleen, this should 
induce a larger fraction of pTregs in LN. Recently, tTregs but not pTregs were 
shown to express Nrp1 at steady state [30; 31]. Using Nrp1 staining for flow 
cytometry, the percentage of Tregs lacking the expression of Nrp1 in LN and 
spleen was determined. A slightly higher percentage of Nrp1- pTregs was 
found in LN in comparison to spleen (27.7 ± 5.0 % in LN and 20.9 ± 2.9 % in 
spleen, n = 7, Fig. 8), which is overall in line with the in silico results. In 
summary, conversion added an important contribution to Treg homeostasis, 
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especially in LN. 
 
Figure 8: Percentage of Foxp3+Nrp1- pTregs slightly differs in LN and spleen. 
Histograms show Nrp1 expression on Tregs in LN and spleen. Cells were gated as 
CD3+CD4+Foxp3+ live singlets. Representative data of seven mice from two independent 
experiments are shown. 
6.1.7. Total number of leukocytes increases in LN but not in spleen 
upon Treg depletion 
In the experiments described above, it was shown that Tnaïves and Tregs 
display different responses to Treg depletion in LN and spleen. For example, 
the number of Tnaïves decreased in spleen but increased in LN. The next 
interesting point was to verify whether other immune cell subsets also show 
differential responses when comparing their LN and spleen populations after 
Treg depletion. Indeed, important changes in the total number of cells were 
observed only in LN but not in the spleen (Fig. 9). The leukocyte number 
dramatically increased within four to six days of Treg depletion in LN, with the 
peak of accumulation being observed between days six and eight. The 
number of cells returned to normal levels 60 days after DT injection. That 
means, although the Treg population achieves homeostatic levels again just a 
few days after depletion (Fig. 9), a disturbance in the total leukocytes 
population of LN lasting for several weeks was observed. 
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Figure 9: Total number of leukocytes increases in LN but not in spleen upon Treg 
depletion. 
Left and right panels show the total number of leukocytes in LN and spleen, respectively. 
Mice were treated with DT at day zero. Red symbols show data from DEREG mice while 
black symbols show data from wildtype mice. Values for individual mice (circles) as well as 
lines connecting means are plotted. Data were pooled from at least two independent 
experiments per time point. * = p < 0.05 at indicated time point. 
 
A range of immune cell subsets is present in LN and spleen in the steady 
state and the next question was which of them change in numbers upon Treg 
depletion. Thereto, multicolor flow cytometry and different antibody 
combinations were applied to analyze immune cell composition in LN and 
spleen of treated mice. The gating strategy is shown in Figure 10. NK cells 
(Fig. 10A), B cells (Fig. 10B), DC, monocytes and neutrophils (Fig. 10C) could 
be distinguished. The next step was to use multicolor flow cytometry to 
determine the kinetics of each of these populations in LN and spleen after 
Treg ablation. 
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Figure 10: Multicolor flow cytometry allows for characterization of the response of a 
range of immune cell subsets to Treg depletion. 
Balloons represent gates and arrows denote when further gating was performed. A: living 
single events were gated for lack of CD3 and CD4. NK cells were defined as CD3-CD4- 
events expressing CD335 (NKp46) and CD122. B: living single events were gated for the 
absence of CD3, CD49b, CD11c and autofluorescence (AF). After that, expression of CD45R 
(B220) was used to define B cells. C: living single events lacking CD3, CD19, CD49b and 
CD45R were gated. After that, neutrophils were defined as Ly6G+ events. Ly6G- events were 
further analyzed based on the presence (DC) or absence of CD11c. Events lacking CD11c 
but expressing both CD11b and high levels of Ly6C were defined as monocytes. 
6.1.8. DC and NK cells transiently accumulate in the LN and spleen 
upon Treg depletion. 
The first immune cell subsets analyzed were the DC and NK cell populations, 
which are controlled by Tregs under homeostatic conditions. Tregs keep 
homeostasis of the DC population via a Flt3-dependent mechanism [44; 45] 
and restrain NK cell numbers by consumption of T cell-produced IL-2 [47-49]. 
In this study, the splenic populations of both DC and NK cells only slightly and 
transiently increased in absence of Tregs, whereas LN DC and NK cells 
became notably more numerous after Treg depletion (Fig. 11). Interestingly, 
the increase in NK cells seemed to anticipate the increase in DC in both 
organs, with LN NK cells achieving high levels already on day 3 but LN DC 
only on day 4. The decline in both cell populations was comparable, starting 
on day 6. Therefore, Treg depletion seems also to differentially influence DC 
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and NK cells when comparing their LN and spleen populations. 
 
Figure 11: DC and NK cells transiently accumulate in the LN and spleen upon Treg 
depletion. 
Left and right panels show the number of indicated cell populations in LN and spleen, 
respectively. Upper panels show data for DC, lower panels for NK cells. DEREG mice (red) 
and wildtype littermates (black) were treated with DT at day zero. Values for individual mice 
(circles) as well as lines connecting means are plotted. Data were pooled from at least two 
independent experiments per time point. * = p < 0.05 at indicated time point. 
6.1.9. mo-DC appear punctually in LN upon Treg depletion 
Inflammation induces monocyte differentiation into antigen-presenting cells, 
so called mo-DC [128]. mo-DC, which are characterized by the expression of 
CD11b and intermediate to high levels of Ly6C and CD11c, are completely 
absent from LN in the steady state (Fig. 12, left panel). Neither before nor 
after treatment mo-DC were found in the spleens (data no shown). 
Interestingly, a population of CD11b+Ly6C+CD11c+ cells appeared in LN upon 
Treg depletion (Fig. 12). The accumulation of mo-DC in LN of Treg-depleted 
mice started at day 2, with sharp increase up to day 4 and a rapid decrease 
afterwards (Fig. 12). Hence, Treg depletion led to a transient accumulation of 
mo-DC in LN. 
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Figure 12: mo-DC appear punctually in LN upon Treg depletion. 
A: gating strategy for mo-DC on day four upon DT is shown. B: the numbers of mo-DC in LN 
are plotted. DEREG mice (red) and wildtype littermates (black) were treated with DT at day 
zero. Values for individual mice (circles) as well as lines connecting means are plotted. Data 
were pooled from at least two independent experiments per time point. * = p < 0.05 at 
indicated time point. 
6.1.10. B cells accumulate for at least three weeks in LN but not in
 the spleen upon Treg depletion 
Tregs were shown to be involved in the control of antigen-specific B cell 
responses [50; 51]. Further, defective B cell anergy as well high titers of 
autoantibodies are found in Foxp3-deficient mice [52; 129]. As seen in Figure 
13, there was a considerable and long-lasting increase in the numbers of B 
cells in LN in the absence of Tregs, while no differences were observed in the 
spleen. The increase in the B cell population in LN, which represents the third 
largest cell population in this organ, might be responsible for the augmented 
total number of cells observed in LN upon Treg depletion (Fig. 9). Although 
one could expect an increased incidence of autoimmunity in mice with such 
an expansion in the B cell population within LN, which is potentially producing 
self-reactive antibodies, no apparent signs of autoimmunity were detected in 
these mice even 60 days after Treg depletion (data not shown).  
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Figure 13: B cells accumulate for at least three weeks in LN but not in the spleen upon 
Treg depletion. 
Left and right panels show the number of B cells in LN and spleen, respectively. DEREG 
mice (red) and wildtype littermates (black) were treated with DT at day zero. Values for 
individual mice (circles) as well as lines connecting means are plotted. Data were pooled 
from at least two independent experiments per time point. * = p < 0.05 at indicated time point. 
6.1.11. CD11b+Ly6C+Ly6G+ and CD11b+Ly6C++Ly6G- cells
 transiently accumulate in both LN and spleen upon Treg
 depletion  
On one hand, DT injection in DEREG mice leads to systemic death of Tregs. 
Hence, an accumulation of phagocytic cells, including neutrophils and 
monocytes, in Treg-depleted mice should be expected. On the other hand, 
the lack of autoimmunity in Treg-depleted DEREG mice makes it tempting to 
speculate whether other immune regulatory cells might be responsible for 
immune modulation in the absence of Tregs. A candidate population for this 
are MDSC, which have the ability to suppress immune responses [54; 55]. 
The numbers of LN and spleen CD11b+Ly6C++Ly6G- and CD11b+Ly6C+Ly6G+ 
cells, which are neutrophils and monocytes in the steady state but also 
include mono-MDSC and PMN-MDSC in certain types of inflammation, were 
determined. Indeed, there was an increase in both populations in LN and 
spleen after DT application in DEREG mice (Fig. 14). Consequently, Treg 
depletion led to an accumulation of cells which might be phagocytic myeloid 
cells, but might also include cells with suppressive activity, exerting immune 
regulation once Tregs are missing. Notably, wildtype littermates receiving DT 
also showed a rapid but short increase in spleen neutrophils (Fig. 14, black 
line of lower right), which might be due to minor contamination of DT with 
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some bacterial products. 
 
Figure 14: CD11b+Ly6C+Ly6G+ and CD11b+Ly6C++Ly6G- cells transiently accumulate in 
both LN and spleen upon Treg depletion. 
Left and right panels show the number of indicated cell populations in LN and spleen, 
respectively. Upper panels show data for CD11b+Ly6C++Ly6G- cells, lower panels for 
CD11b+Ly6C+Ly6G+ cells. DEREG mice (red) and wildtype littermates (black) were treated 
with DT at day zero. Values for individual mice (circles) as well as lines connecting means 
are plotted. Data were pooled from at least two independent experiments per time point. * = p 
< 0.05 at indicated time point. 
 
In the first part of this study, Treg homeostasis as well as their role in keeping 
immune balance was investigated. In summary, the relative contributions of 
different mechanisms to Treg homeostasis in mice were investigated, 
showing that they quantitatively differ in LN and spleen. These findings are 
supported by the first multi-organ mathematical model of Treg homeostasis 
and Tnaïve recirculation in mice, created in co-operation with Prof. Dr. 
Michael Meyer-Hermann. Further, it was examined how immune cell subsets 
such as B cells, NK cells and myeloid cells respond to the absence of Tregs 
in LN and spleen, demonstrating that Treg-mediated regulation acts in a 
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broad immunological context with important differences in LN and spleen  
 Role of MDSC in IAV infection 6.2.
6.2.1. Murine lungs contain cells that express markers of monocytes 
and mono-MDSC before and after IAV infection  
In the second part of this thesis, the aim was to examine the role of MDSC in 
IAV infection. Monocytes were claimed to be the “necessary evil” of the 
immune response against IAV. Avoiding their accumulation either genetically 
or chemically led to an overall improvement in mouse survival [65; 107]. In 
those studies, monocytes were termed inflammatory cells but their potential 
differentiation into mono-MDSC was not considered, maybe because MDSC 
were almost exclusively described in chronic but not in acute viral infection. It 
was therefore interesting to answer the question whether the mononuclear 
myeloid cells that accumulate in the lungs upon IAV infection also have a 
CD11b+Ly6C++Ly6G- phenotype. The lungs of PBS-treated, healthy control 
mice contained a small population of CD11b+Ly6C++Ly6G- cells (Fig. 15 “d0”), 
which were likely monocytes. Importantly, CD11b+Ly6C++Ly6G- cells were 
also found in infected lungs six days upon infection with IAV (Fig. 15 “d6”). 
Since the existence of cells with this phenotype at inflamed sites was 
associated with the presence of mono-MDSC, theses findings were 
interpreted as a first hint that mono-MDSC might indeed accumulate in IAV-
infected lungs. 
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Figure 15: The murine lungs contain cells that express markers of monocytes and 
mono-MDSC before and after IAV infection. 
Panels show the gating strategy for CD11b+Ly6C++Ly6G- cells. Cells were isolated from lungs 
of PBS-treated (left, d0) mice or IAV-infected mice on day six of infection (right, d6). Top 
panels were pre-gated on single events after exclusion of dead cells. Plots are representative 
for two independent experiments each with three to five mice per time point. 
6.2.2. CD11b+Ly6C++Ly6G- cells partially express DC maturation and 
activation markers 
Lung-infiltrating monocytes were previously described to mature in the lung 
and give rise to TiP-DC upon IAV infection [65; 107]. The next step was 
therefore to determine the phenotype of CD11b+Ly6C++Ly6G- cells before and 
after infection with regard to the expression of cell markers associated with 
DC differentiation. Before infection, monocytes expressing CD11c, MHCII or 
CD86 could hardly be found (Fig. 16, gray shadow). Six days after infection, 
between 40 % and 50 % of the CD11b+Ly6C++Ly6G- cells found in the lung 
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expressed MHCII or CD11c (Fig. 16, left and central panels). The expression 
of CD86 was even more frequent with about 80 % the CD11b+Ly6C++Ly6G- 
cells expressing this marker (Fig. 16, right panel). Therefore, a part but not all 
lung CD11b+Ly6C++Ly6G- cells seemed to be mature inflammatory TiP-DC 
upon IAV infection. 
 
Figure 16: CD11b+Ly6C++Ly6G- cells partially express DC maturation and activation 
markers. 
Panels show expression of CD11c, MHCII and CD86 on lung CD11b+Ly6C++Ly6G- cells pre-
gated as in Figure 15. Cells were isolated from lungs of PBS-treated mice (gray shadow) and 
IAV-treated mice on day six of infection (black line). Numbers denote mean frequency ± 
standard deviation of gated cells among total CD11b+Ly6C++Ly6G- cells. Data are from 
representative mice from two independent experiments with a total of three (d0) or four mice 
(d6). 
6.2.3. CD11b+Ly6C++Ly6G- cells isolated from the lung or spleen of 
IAV-infected mice show suppressive activity 
Until now, only a functional assay can prove that CD11b+Ly6C++Ly6G- cells 
accumulating at sites of inflammation are indeed mono-MDSC. This is due to 
a lack of surrogate markers that can be used to unambiguously identify them. 
Therefore the next aim was to assess the functional activity of cells 
accumulating in infected lungs. CD11b+Ly6C++Ly6G- cells were sorted from 
the murine lungs or spleens six days upon IAV infection and incubated them 
with CFSE-labeled Tnaïves in vitro in the presence of anti-CD3/anti-CD28 
antibodies. This was to test whether IAV mono-MDSC show suppressive 
activity. CD11b+Ly6C++Ly6G- cells from both organs were able to suppress, at 
least partially, Tnaïve proliferation (Fig. 17A-B). This result demonstrates that 
IAV leads to the accumulation of CD11b+Ly6C++Ly6G- cells with a bona fide 
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mono-MDSC phenotype i.e. with the ability to suppress a T cell response. It 
also confirms that mono-MDSC can appear during acute virus infection. 
 
Figure 17: CD11b+Ly6C++Ly6G- cells isolated from the lung or spleen of IAV-infected 
mice show suppressive activity. 
Upper panel shows histograms with dilution of CFSE in Tnaïves (pre-gated as living single 
CD4+CD11b- cells) incubated for four days either in absence (- stimulus) or presence (+ 
stimulus) of anti-CD3/CD28 and added mono-MDSC sorted as in Figure 15 from the lungs or 
spleens of IAV-infected mice at a 1:1 ratio. Numbers show frequency of cells that underwent 
at least one division. Each condition was performed in triplicates and shown are 
representative data. Lower panel shows geometric mean fluorescence intensity (geo mean) 
of CFSE in Tnaïves pre-gated as in upper panel, but with different mono-MDSC:Tnaïve 
ratios. Data from two independent experiments were pooled. 
6.2.4. Peak of mono-MDSC accumulation is followed by an increase 
in the absolute number of T cells 
Mono-MDSC, which show suppressive activity towards T cells, can be found 
after IAV infection (Fig. 17). The next step was to determine the kinetics of 
mono-MDSC and T cell accumulation in the lungs of IAV infected mice to 
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evaluate whether presence of these cell populations overlap in situ. On day 
six after infection, which is also roughly the time when mice start recovering 
body weight (data not shown), mono-MDSC numbers have already reached 
their highest levels but only few T helper cells and CTL could be found in situ 
(Fig 17). On day seven, the number of mono-MDSC was similar as on day six 
and steadily decreased afterwards. Also on day seven, the population of T 
helper cells achieved its plateau, with similar cell numbers being found until 
day ten. The CTL population achieved its highest numbers on day eight, 
which remained stable also on day ten. On day 14, all cell populations were at 
very low numbers again (Fig 17). Therefore, although mono-MDSC precede T 
cell accumulation in the lungs, presence of both cell subsets in situ overlaps 
for some days during initiation of the adaptive response. Since animals start 
regaining body weight in this phase, an indication of effective virus clearance, 
and since T cells play a determinant role in this phase [130; 131], the results 
indicates that mono-MDSC do not hamper a proper T cell response to the 
virus. 
 
Figure 18: Peak of mono-MDSC accumulation is followed by an increase in the 
absolute number of T cells. 
Bar graph shows the number of total mono-MDSC, CD8+ CTL and CD4+ T helper cells 
(CD3+CD8+ and CD3+CD4+Foxp3- single living events, respectively) in the lungs of PBS-
treated (d0) or IAV-infected mice on indicated days after infection as determined by flow 
cytometry. Data were pooled from two independent experiments each with three to five mice 
per time point. 
6.2.5. IFNγ triggers iNOS expression in IAV-induced lung mono-
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cells (Fig. 17) and the presence of mono-MDSC and T cells overlap for some 
days in IAV-infected lungs (Fig. 18). A previous study from our group pointed 
out that the IFNγ/iNOS axis plays a key role in controlling Th1-induced 
inflammation [132]. Moreover, although iNOS is expressed by TiP-DC at 
inflamed sites, likely mediating killing of invading pathogens [133], this 
enzyme is also among the most important effector molecules mediating 
suppression by MDSC [54]. So, the aim was to determine the kinetics of IFNγ 
availability in lung tissue as well as iNOS-production by mono-MDSC in IAV-
infected lungs during the course of infection. A strong correlation between 
presence of IFNγ and numbers of iNOS-expressing mono-MDSC in IAV-
infected lungs was observed (Fig. 19A and B). IFNγ and iNOS-expressing 
cells were hardly detectable in lungs until day five of infection. Remarkably, 
on day six, although only few T helper cells and CTL were found in the IAV-
infected lungs (Fig 18) and T cells are the main source of IFNγ during IAV 
infection [104; 134], the highest amount of IFNγ and the highest number of 
iNOS-producing mono-MDSC were observed on this day (Fig. 19A and B). 
Surprisingly, at later stages, when T cells heavily accumulated in the IAV-
infected lungs (Fig 18), IFNγ and the number of iNOS-expressing cells 
steadily decreased and eventually reached normal levels already at day ten 
(Fig. 19A and B). An in vivo injection with a monoclonal anti-IFNγ blocking 
antibody on day five of infection led to a significant decrease in the number of 
iNOS+ mono-MDSC one day later (Fig. 19C and D). In contrast to previous 
observation from our group [132], however, IFNγ neutralization in vivo did not 
change outcome of disease (Fig. 20). When comparing infected mice treated 
either with isotype control or anti-IFNγ antibody, no differences were 
observed in loss of body weight and in lung damage (Fig. 20). Hence, a wave 
of IFNγ availability on day six of infection led to a considerable response by 
mono-MDSC in the form of iNOS expression. Notably, this kinetics correlates 
with the initiation of adaptive immunity in the murine model of IAV infection, 
which starts at around one week after infection and leads to viral clearance 
[103; 135]. 
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Figure 19: IFNγ triggers iNOS expression in IAV-induced lung mono-MDSC. 
A: The concentration of IFNγ in lung homogenate of PBS-treated (d0) and IAV-infected mice 
on indicated days after infection as determined by ELISA is shown. Lung homogenates from 
four to six mice per time point from two independent experiments were analyzed in one 
ELISA experiment. B: The number of iNOS-producing mono-MDSC in the lungs of PBS-
treated (d0) and IAV-infected mice on indicated days after infection as determined by flow 
cytometry (iNOS+ events, pre-gated similar as in Figure 15) is shown. Data were pooled from 
two independent experiments each with three to five mice per time point. C: Panels show 
expression of iNOS by lung mono-MDSC (pre-gated as in Figure 15) from IAV-infected mice 
on day six after infection and either injected with IgG isotype control (IgG) or anti-IFNγ 
(aIFNγ) antibody one day before. One representative mouse per treatment from two 
independent experiments with a total of five (IgG) or seven (aIFNγ) mice are shown. 
Numbers are percentages of iNOS+ events among mono-MDSC. D: Bar graph shows the 
mean number of iNOS-producing mono-MDSC in the experiments shown in C. Data were 
pooled from both independent experiments. Error bars in all graphs show standard deviation. 
* = p < 0.05. 
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Figure 20: IFNγ blockade during IAV infection does not change disease outcome. 
A: mean percentages of initial body weight of IAV-treated mice on different days after 
infection and either injected with anti-IFNγ (red symbols) or IgG isotype control (black 
symbols) on day five of infection are shown. B and C: Mice were sacrificed on day 14 of 
infection and their lungs isolated for histological analysis. Representative pictures are shown 
in B, the mean clinical scores of mice in different groups are shown in C. Error bars show 
standard deviation. Data in A and C were pooled from two independent experiments each 
with five mice per group. 
6.2.6. T cell suppression by lung IAV mono-MDSC is not triggered by 
IFNγ in vivo 
Previous work from our lab showed an essential role of IFNγ in switching on 
iNOS expression and, thereby, triggering suppressive activity in MDSC 
(unpublished data and [132]). Therefore, it was of interest to analyze whether 
IFNγ is also responsible to elicit suppression of T cell proliferation by mono-
MDSC in the lungs of IAV infected mice. Thereto, in vitro suppression assays 
were performed using mono-MDSC isolated from lungs of mice on day six of 
IAV infection and treated the day before with isotype control or with anti-IFNγ 
antibody. Although IFNγ neutralization successfully blocked iNOS expression 
by mono-MDSC (Fig. 19), suppression activity was not different when 
comparing control and anti-IFNγ-treated groups (Fig. 21). This indicates that 
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IFNγ is not needed to trigger suppressive activity in mono-MDSC in the lungs 
of mice infected with IAV. 
 
Figure 21: T cell suppression by lung IAV mono-MDSC is not triggered by IFNγ in vivo. 
Histograms show dilution of CFSE in Tnaïves pre-gated and incubated as in Figure 17 but 
with mono-MDSC being isolated from day six IAV-infected mice either treated with rat IgG 
isotype control or anti-IFNγ on day before. Numbers show frequency of T cells undergoing at 
least one division. Each condition was performed in triplicates and representative data are 
shown. Data from one out of two independent experiments with comparable results are 
shown. 
6.2.7. T cell suppression by lung IAV mono-MDSC is iNOS-
dependent 
Finally, the aim was to examine the mechanism of suppression of T cell 
proliferation by IAV-induced lung mono-MDSC. iNOS, Arg1 and IDO, three 
amino acid-catabolizing enzymes described to contribute to MDSC-mediated 
T cell suppression in different settings, are potently inhibited by the 
commercially available chemical compounds L-NMMA, NOR-NOHA and 1-
MDT, respectively [136-138]. Therefore in vitro suppression assays with ex 
vivo isolated, IAV-induced lung mono-MDSC in the presence or absence of 
these compounds were performed. Chemical inhibition of Arg1 and IDO had 
no effect on suppressive activity (Fig. 22). However, addition of the iNOS 
inhibitor completely blocked suppressive activity by IAV-induced lung mono-
MDSC (Fig. 22). Hence, iNOS activity is the key mechanism applied by 
mono-MDSC from lungs of IAV-infected mice to suppress T cell proliferation. 
Taken together, the data show that mono-MDSC accumulate in the lungs of 
IAV-infected mice in the beginning of the adaptive response, suppressing T 
cell proliferation via iNOS expression. 
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Figure 22: T cell suppression by IAV-induced lung mono-MDSC is iNOS-dependent. 
A: histograms show dilution of CFSE in Tnaïves pre-gated and incubated as in Figure 17 but 
in presence or absence of NOR-NOHA, 1-MDT or L-NMMA (inhibitors of arginase, IDO and 
NOS, respectively). Numbers are frequencies of T cells undergoing at least one division. 
Each condition was performed in triplicates and representative data are shown. Data from 
one out of two independent experiments with comparable results are shown. B: geometric 
mean fluorescence intensity (geo mean) of CFSE in Tnaïves from the same experiment as in 
A is shown. Error bars show standard deviation. 
 
In summary, the results reported in the second part of this thesis provide 
evidence that IAV induces accumulation of mono-MDSC with the ability to 
suppress T cell proliferation. These observations shed new light on the role of 
lung-infiltrating monocytes, which have long been considered to enhance 
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inflammation during IAV infection. The data indicate that at least part of the 
infiltrating monocytes are not fully differentiated TiP-DC and have the ability to 
inhibit a T cell response by means of iNOS expression, a hallmark of MDSC.  
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7. Discussion 
The results from the first part of this study presented indications that the 
mechanisms contributing to Treg homeostasis in LN and spleen quantitatively 
differ. This was supported by a combined in vivo and in silico approach, for 
which the first multi-organ mathematical model of Treg homeostasis in mice 
was built. Additionally, using an in vivo Treg depletion strategy, Treg-
mediated immune homeostasis was described to act in a broad 
immunological context, affecting a range of immune cell subsets such as B 
cells, NK cells and myeloid cells. Here again, fundamental differences in the 
responses in LN and spleen were observed. These findings might be of 
relevance since Treg depletion is currently considered a potential strategy for 
boosting vaccination and immunotherapies, making it essential to understand 
how the immune system reacts as a whole to such an intervention. The 
second part of this work focused on the role of MDSC in IAV infection and the 
results contributed evidence that mono-MDSC, which are able to suppress T 
cells, accumulate after acute respiratory infection with IAV. Since monocytes 
are considered to induce strong inflammation upon infiltration into IAV-
infected lungs, these observations expand the knowledge on the role of 
monocytes during IAV infection. These findings should lead to a 
reconsideration of the role of monocytes in IAV infection as well as lead the 
way to further studies on the development of MDSC in acute infections. 
 Tregs and their role in keeping immune homeostasis in 7.1.
secondary lymphoid organs  
7.1.1. Mechanisms of Treg homeostasis quantitatively differ in LN 
and spleen 
T cell populations were observed to differ in LN and spleen in homeostatic 
state. The ratio of Tregs to Tnaïves is higher in the spleen, and the 
percentage of CD69+ Tnaïves and Tregs is higher in LN. This was considered 
to be in agreement with the magnitude of antigen presentation, which is 
assumed to be lower in spleen, where adaptive immunity is initiated in case of 
blood-borne pathogen infection, and higher in peripheral LN, which 
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permanently survey a plethora of skin commensals and potentially pathogenic 
agents [42; 139]. Beside the differences observed in homeostatic state, it was 
also found here that Tnaïve dynamics fundamentally differ in LN and spleen 
following in vivo Treg depletion. The spleen was characterized by a transient 
reduction of the total Tnaïve population, in sharp contrast to LN, where 
Tnaïves transiently accumulated. Interestingly, only by introducing the 
assumption that Tregs influence Tnaïve migration it was possible to 
reproduce these experimental data in silico. In addition to direct killing and 
inactivation of Tnaïves by Tregs as well as indirect suppression by 
competition for antigen-presenting cells and cytokines [120], these results 
may add a new layer of immune control by Tregs, namely modulation of T cell 
migration properties. Keeping in mind the efforts to modulate Treg activity in 
clinical settings [2; 3], further studies should consider relocation of Tnaïves 
between different organs as a side effect of treatment. Further, only a 
dynamic recirculation of Tnaïves between LN and spleen could describe the 
in vivo results, implicating that factors influencing Tnaïve motility sense 
changes in population size. Such a quorum sensing-like mechanism has been 
reported to control homeostasis of T cell numbers [140]. The results 
described here expand this notion by adding that quorum sensing might also 
regulate trans-organ migration. However, it cannot be excluded that more 
complicated mechanistic differences between the organs would also 
contribute to the structural differences in the reconstitution dynamics. 
Tnaïves use similar pathways to pass through LN and spleen [139; 141]. 
Tnaïves in peripheral blood expressing CD62L and CCR7 interact with high 
endothelial venules (HEV) of LN, which eventually leads to transendothelial 
migration and LN entry. Similarly, Tnaïves flowing with the blood stream 
within the marginal sinus and marginal zone of the spleen use related 
molecular pathways to achieve the splenic white pulp [139; 141]. Exit of LN 
and spleen is regulated by sphingosine-1-phosphate sensing in both LN and 
spleen [139; 141]. One important difference between LN and spleen with 
regard to Tnaïve migration is the exclusive presence of HEV in LN [142]. 
Interestingly, DC were shown to control T cell entry to LN via modulation of 
HEV function and it was discussed whether DC can regulate not only 
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phenotype but also growth of HEV [142; 143]. Since DC homeostasis is 
maintained by Tregs [44; 45], Tregs might be at least indirectly involved in 
HEV homeostasis. There is evidence for this assumption coming from studies 
of tumor-bearing mice in which Treg depletion leads to increased HEV 
formation within tumors [144]. This was associated with higher T cell 
infiltration and enhanced tumor control. To test whether Treg depletion 
changes HEV phenotype and/or growth, it would be interesting to quantify the 
number of HEV in LN of DEREG mice after DT injection as well as to assess 
their expression of maturation markers. This could be achieved by 
immunohistochemical staining for CD31, MECA-79, GLYCAM1, FucT-VII, 
GlcNAc6ST-2 and MADCAM1, as mature HEV were described to have a 
MECA-79+GLYCAM1+FucT-VII+GlcNAc6ST-2+MADCAM1- phenotype [143]. 
In case Tregs indeed control HEV homeostasis not only in tumors but also in 
LN, this could have effects on lymphocyte migration specifically in LN but not 
in spleen, which in turn could explain some of the differences observed here 
with regard to differential accumulation of Tnaïves and other immune cell 
subsets in LN and spleen.  
Interestingly, the measured steady state size of T cell subsets imposed to the 
mathematical model that Treg migration between organs is reduced at least 
4-fold compared to Tnaïves. Furthermore, including Treg trans-organ 
migration into the fit routine resulted in a negligible amount of Treg migration. 
When imposing Treg trans-organ migration at 20 % of the migration rate of 
Tnaïves, a fit of comparable quality was generated but at the price of 
unrealistic resting state recirculation frequencies which are in contradiction 
with the known passage times of six to eight hours for Tnaïves in LN [124-
126]. These data suggest that Tregs are more sessile than Tnaïves. This 
assumption is supported by the finding that the T cell receptor repertoire of 
Tregs but not of Tnaïves is clearly different in different LN [145]. However, the 
presence of Tregs in peripheral blood suggests that Treg indeed recirculate. 
Since Treg subsets were not considered in the model, it could be that the 
reduced Treg migration that was predicted here reflects the Treg 
compartment as a whole but does not hold necessarily true for each of the 
Treg subsets. It would be interesting to expand the model and include cTregs 
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and eTregs, for example, which have different migratory properties [33; 34]. In 
summary, the framework of the presented model predicts that Treg 
recirculation is reduced in comparison to Tnaïves, although the quantitative 
degree of Treg recirculation could not be identified and needs to be further 
investigated. 
Depletion of 50 % of Tregs in mice was described before to induce an 
overshoot of Tregs in peripheral blood and spleen within some days, which 
was followed by a slow decrease to normal level after some weeks [121]. The 
results presented here also show that the Treg population reaches a size that 
is larger than the original homeostatic size upon both in vivo and in silico 
depletion and reconstitution. According to the model, this result depends on 
two important features. First, the rates of each mechanism contributing to the 
Treg population have to adapt to the Treg rebound with a delay. A fast 
depletion induces strongly changed target parameter values in all processes 
contributing to Treg reconstitution. The delay in adopting these target values 
induces the overshoot, because the populations also do not stop the 
reconstitution process instantly. Secondly, the model predicts that the 
overshoot only appears for strong depletions of 90 % and more (data not 
shown). For less strong depletions, reconstitution is slower, growing beyond 
the original homeostatic population size after two weeks in LN but not in 
spleen. This result does not reflect the data from 50 % depletion model 
described above [121], but is supported by another previous study in which 
depletion of Tregs by 70 % led to a rebound without overshoot in LN and 
spleen [127]. Independent of which percentage of Tregs depleted exactly 
leads to an overshoot of Tregs in mice and keeping in mind the potential of 
Treg depletion in the clinics mentioned before, it should be taken into 
consideration whether a too strong Treg depletion in clinical settings might 
induce a subsequent state of excessive tolerance due to a Treg overshoot. 
This could be actually rather prejudicial for cancer patients, for example, since 
Tregs are known to hamper a proper anti-tumor response. 
IL-2 signals through its high affinity heterotrimeric receptor after binding to 
CD25 alone [123]. This leads to conformational changes in the IL-2 molecule, 
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which promotes binding of CD122 to IL-2, and the complex consisting of IL-2, 
CD25 and CD122 then binds to CD132. Phosphorylation of tyrosine residues 
in the CD122 tail then initiates a cascade pathway eventually leading to 
internalization and degradation of IL-2 [123]. On one hand, Tregs use this 
pathway to consume IL-2 from its environment and, on the other hand, IL-2 
signaling is key to normal Treg homeostasis in peripheral organs [19; 20]. 
Surprisingly, CD122 is rapidly downregulated from the surface of Tregs upon 
DT treatment in DEREG mice. Since DT disrupts protein synthesis upon 
penetration into target cells [146], this result indicates a short half-life for 
CD122 in Tregs. It seems that a stable expression of this molecule on the 
Treg surface demands a continuous production of CD122 itself or of 
accessory proteins involved in CD122 transport to the cell surface. CD25 was 
not downregulated like CD122 in the Treg depletion experiments (data not 
shown), indicating that the different chains of the IL-2 receptor are 
differentially regulated. Indeed, among the IL-2 receptor chains, only CD25 is 
recycled to the cell surface upon IL-2-binding and internalization, whereas 
CD122 and CD132 are degraded [123]. Given its importance in Treg 
homeostasis, it would be intriguing to test whether the sensitivity of CD122 to 
protein synthesis-disrupting pathways is specific for Tregs or a broad 
regulatory mechanism present in other CD122-producing cells. Future studies 
could try to figure this out and, in case this phenomenon is Treg-specific, it 
could be explored in strategies aiming at disturbing Tregs in vivo. 
The results presented here shed light on a fundamental part of Treg 
homeostasis, which is the extrathymic generation of Tregs. A basal level of 
conversion takes place in the steady state, which is in accordance with the 
hypothesis that peripheral homeostasis depends on presentation of self, food 
and flora-derived antigens under tolerogenic conditions, leading to conversion 
of Tnaïves into pTregs [25; 147]. Here again, an essential difference between 
LN and spleen was observed. In comparison, approximately three times more 
pTregs appear daily in LN. Although this was not considered as a quantitative 
prediction, it seems reasonable that Treg induction in LN takes place at 
higher rates than in spleen. Further, the contribution of conversion to Treg 
homeostasis in LN was predicted to be at least as important as thymic output 
DISCUSSION 
 58 
and homeostatic proliferation. This goes in line with the differences in the 
nature of antigen presentation in both organs, as LN are supposed to be a 
site prone to tolerance induction [148-150]. A recent study claimed that only 
migratory DC, which are hosted in LN but not in spleen, are able to induce 
conversion of Tnaïves into pTregs, restricting development and presence of 
converted Tregs to LN [151]. The results only partially reflect those findings, 
as a basal level of conversion in spleen was also found, which has also been 
reported by others [152]. Moreover, different groups have reported that 
different DC types from different organs favor tolerance via Treg induction 
[150; 153-156], so that it will be tempting to expand the model in order to 
predict what happens in other organs, such as the gastrointestinal tract, lung 
and liver, where peripheral Treg conversion and expansion plays an important 
role for maintenance of tolerance [157-160]. 
The detailed approach presented here, combining highly time-resolved 
experimental data with a mathematical model, gave new and important 
insights into Treg biology. Such quantitative approaches applied to studies of 
infection, organ transplantation or autoimmunity could pave the way to a more 
refined understanding of T cell homeostasis. 
7.1.2. Broad context of immune regulation by Tregs and its 
underlying differences in LN and spleen 
DC and NK cells showed a quite similar response to Treg ablation, 
accumulating rapidly in LN, which was maintained for around one week, but 
accumulating in spleen only after day six of DT injection, which lasted a 
shorter period of time. Tregs are known to control the size of both DC and NK 
cell populations [44; 45; 47-49], so that a direct effect of Treg depletion on DC 
and NK cells should be expected. However, the similar pattern of response 
observed might also be caused by a direct interaction between DC and NK 
cells, as described before. DC express the IL-15 receptor α chain, which is 
necessary for trans-presentation of IL-15, a survival and growth factor for 
mature NK cells in the periphery [161]. Accordingly, an increase in the 
number of DC should lead to an increase in IL-15 trans-presentation followed 
by an increase in the NK cell population. The Treg/DC/NK cell axis was 
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discussed before [162]. The authors showed that Tnaïve/DC interaction in the 
absence of Tregs led to enhanced IL-15 trans-presentation by DC in vitro, 
which in turn was claimed as mechanism contributing for NK cell 
accumulation in Treg-depleted secondary lymphoid organs [162]. Further 
investigations on the direct role of DC in controlling the NK cell population in 
vivo in the absence of Tregs could be performed, for example, by application 
of anti-IL-15 blocking antibody following Treg depletion in DEREG mice.  
A surprising finding in this study was the appearance of mo-DC in Treg-
depleted LN. As noted above, mo-DC are neither present in LN nor spleen in 
the steady state, but can be readily found in LN four days after DT treatment 
in DEREG mice. Their presence was tightly controlled in time. 
Mechanistically, it might be due to monocyte activation by danger signals as a 
consequence of massive Treg death [163]. Since the spleen is responsible for 
blood filtering and elimination of dying erythrocytes, its apparatus for 
clearance of dead cells is likely much more efficient than that in LN [139]. This 
would mean that Treg death in peripheral tissues and their draining LN might 
induce much stronger danger signals when compared to death signal in the 
blood and spleen, leading to monocyte activation exclusively in LN. To assess 
whether mo-DC accumulation is indeed only due to accumulation of dead 
cells in peripheral tissues and LN and is not Treg-specific, DT injection in 
mice with bone marrow chimerism giving rise to 90 % wildtype T cells and 10 
% T cells expressing the DT receptor [164] would provide a clearer picture. 
Such control experiments should also allow for discriminating whether other 
effects observed here after Treg depletion are indeed due to a Treg-specific 
role rather than due to a role of accumulation of dead cells. Independent of its 
mechanistic cause, induction of mo-DC in LN might be of special relevance 
considering the efforts for the development of strategies for vaccination 
boosting based on Treg depletion. mo-DC were described to express CCR7 
as well as co-stimulatory molecules, such as CD40, CD80 and CD86, making 
them able to migrate to LN and potently present antigens in the context of 
both MHCI and MHCII [165]. It would be intriguing to test whether mo-DC 
accumulating in LN four days after Treg depletion can be used as targets for 
improving antigen presentation with the aim of boosting vaccination. 
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B cells are lymphocytes with the ability to produce antibodies. B cell 
development takes place in the bone marrow, where newly generated B cell 
receptors recognizing self-antigens are deleted from the repertoire. B cell 
deletion is one mechanism to prevent B cell recognition of own antigens. In 
secondary lymphoid organs, mature B cells, upon antigen recognition, interact 
with their cognate T cells, become activated, proliferate and secrete 
antibodies. Since the T cell repertoire is also selected not to react to self-
antigens, T cell-mediated help of B cells is another mechanism for avoidance 
of a mistaken B cell response. Here it was found that B cells heavily 
accumulated in LN missing Tregs, which did not happen in the spleen. This 
observation makes it tempting to speculate on whether Tregs mediate B cell 
tolerance, which has been suggested before [50-52; 129]. Since activated 
Tnaïves, which can give rise to Tfh cells, accumulated alongside B cells in 
LN, it could be that Tregs indirectly control B cell homeostasis via modulation 
of Tfh cells. An argument against a role for Tregs in directly or indirectly 
controlling B cells is the fact that no overt signs of autoimmunity were 
observed in Treg-depleted mice even when they were kept for two months 
after treatment, although the very fast rebound of Tregs could have stopped B 
cells from developing a full response. Another explanation for the increased 
number of B cells in LN is that Tregs might control migration rather than 
activation/proliferation of B cells in this organ. Naïve B cells use similar 
pathways as Tnaïves to enter and exit LN, with selectins and CCR7-
dependent interaction with HEV leading to LN entrance [166]. Therefore, it 
could be that Treg control of B cell accumulation in LN depends on similar 
mechanisms as those discussed above for Tnaïves. Again, such mechanisms 
could also explain why, in general, different lymphocyte subsets were 
observed accumulating selectively in LN but not in spleen. 
In the steady state, neutrophils and monocytes are characterized as 
CD11b+Ly6C+Ly6G+ cells and CD11b+Ly6C++Ly6G- cells, respectively [167]. 
Under certain inflammatory conditions, especially those found in chronic 
disease, these markers are also expressed by PMN-MDSC and mono-MDSC, 
respectively. A transient increase in the populations of CD11b+Ly6C+Ly6G+ 
and CD11b+Ly6C++Ly6G- cells was detected in both LN and spleen upon Treg 
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ablation. In vivo Treg ablation leads to a very rapid accumulation of dead 
Tregs, which have to be promptly removed. Professional phagocytic cells 
such as monocytes and neutrophils exert this cleaning function. Therefore, 
accumulation of CD11b+Ly6C+Ly6G+ and CD11b+Ly6C++Ly6G- cells in LN 
and spleen might be reflecting a systemic response to massive cell death with 
an increase in phagocytic cells. Other transgenic mouse lines, in which 
depletion of immune cell subsets are allowed by targeted DT receptor 
expression, also show accumulation of phagocytic cells [168]. From another 
point of view, one could speculate that CD11b+Ly6C+Ly6G+ and 
CD11b+Ly6C++Ly6G- cells might be MDSC taking over immune control in 
absence of Tregs. This could also explain the lack of autoimmunity in DT-
treated adult DEREG mice [111]. Both assumptions might be true and 
examining the suppressive activity of CD11b+Ly6C+Ly6G+ and 
CD11b+Ly6C++Ly6G- cells from Treg-depleted mice would help answering this 
question. 
In conclusion, Tregs were shown to be involved in controlling the immune 
response in a wide manner. Although further studies will be necessary for 
answering mechanistic questions, taken together the data demonstrate that 
immune modulation might be differentially achieved in LN and spleen, which 
could reflect the anatomical organization and function of these organs. 
Understanding how this takes place might help the development of more 
efficient immunotherapies and vaccination strategies boosting immune 
responses against chronic infections and tumors. 
 Accumulation of mono-MDSC during IAV infection 7.2.
Many factors are involved in immune regulation during IAV infection. An 
elegant work surprisingly showed that IL-10 production by virus recognizing-
specific, effector T cells is crucial to avoid immune-mediated lung disease and 
death in IAV-infected mice [104]. Tregs also seem to be involved in the 
immune response to IAV, since an expansion of IAV-specific Tregs in the 
lungs of infected mice was reported [105]. Despite the many pathways of 
immune regulation during IAV infection, the virus can induce excessive lung 
inflammation. Lung infiltration by monocytes, for example, is considered 
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detrimental for IAV infected mice, as these cells differentiate in situ into TiP-
DC and exert overwhelming pro-inflammatory functions [65; 107; 108]. In the 
present study, new evidence was described that lung-infiltrating monocytes 
might actually exert an anti-inflammatory function, since they were able to 
suppress a T cell response. One explanation for this discrepancy – namely, 
the previously unrecognized anti-inflammatory role of lung infiltrating 
monocytes in IAV infection – might come from the fact that by now it is still 
difficult to distinguish between the progeny of infiltrating monocytes by means 
of surface markers and to study their function with in vitro functional assays. 
In one of the studies cited above, the authors combined the markers CD11c, 
MHCII, CD11b and Gr1 to sort and compare different lung cell populations 
with regard to their ability to induce proliferation of TCR-transgenic CD8+ T 
cells isolated from the spleen of naïve mice [65]. In the other study, 
CD11b+Ly6C++ cells from the bronchoalveolar lavage of infected mice were 
sorted and examined for their ability to induce IL-2 expression in cells from a 
TCR-transgenic CD8+ T cell hybridoma [107]. In this study, lung 
CD11b+Ly6C++Ly6G- cells were evaluated for their ability to suppress 
proliferation of polyclonally activated, wildtype CD4+ Tnaïves. Therefore, 
direct comparison of the studies is challenging. Indeed, monocytes might 
differentiate in the same infected lung into either TiP-DC or mono-MDSC only 
depending on the microenvironmental milieu they are exposed to. Future 
work on additional differentiation markers and standardized functional assays 
are needed to shed light on the progeny of lung-infiltrating monocytes in IAV 
infection. A promising approach might involve transcriptome-based network 
analysis, which was used recently for, among others, a systematic phenotypic 
and functional characterization of human monocyte-derived macrophages 
upon activation [169]. 
IFNγ clearly plays a pleiotropic role in immune responses. Besides its pro-
inflammatory activity, enhancing and/or inducing expression of MHCI and 
MHCII molecules and activating monocytes and macrophages, it can also 
promote isotype class-switch in B cells [170]. Interestingly, IFNγ can even 
dampen inflammation via, for example, induction of iNOS and IDO expression 
[171; 172]. In the present study, although blocking IFNγ in vivo led to a 
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significant decrease in the number of iNOS-producing cells in the lungs of 
IAV-infected mice, there was no difference in lung immunopathology as 
measured by changes in body weight and histology analysis. Furthermore, 
mono-MDSC from anti-IFNγ injected mice were able to suppress T cell 
proliferation in vitro as well as mono-MDSC from isotype control-injected 
mice. This was unexpected since previous work from our group with in vivo 
blockade showed that IFNγ has anti-inflammatory properties and plays a 
protective role in an antigen-specific, Th1-mediated skin inflammation model 
by inducing the local production of iNOS [132]. The discrepancy in the 
outcome of blocking IFNγ in immunopathology observed in these two models 
might arise from the inability of blocking IFNγ to completely stop iNOS 
expression in the IAV model – some iNOS+ cells could still be found after 
treatment. It could also be that other, redundant regulatory mechanisms, such 
as enhanced Treg activity and production of IL-10 by infiltrating T cells, avoid 
lung damage during IAV infection in the absence of iNOS. Alternatively, the 
divergence might come from intrinsic differences in each model. The Th1-
mediated skin inflammation model was induced by injection of antigen-
specific, in vitro differentiated Th1 cells followed by subcutaneous application 
of the cognate antigen together with incomplete Freud adjuvant [132]. This 
model triggers a sterile inflammation of the skin. In contrast, the murine IAV 
infection model triggers a virus-mediated inflammation in the lungs. 
Therefore, both the nature of inflammation (sterile vs. non-sterile) as wells as 
its anatomical localization (skin vs. lung) might lead to different roles of IFNγ 
and/or different sensitivity of mono-MSDC to IFNγ. For a clearer picture of the 
role of IFNγ in this process, it could be informative to perform suppression 
assays with mono-MDSC isolated from the lungs of IAV-infected mice 
previously subjected to bone marrow chimerism using congenic-marked 
IFNγR+/+ and IFNγR-/- cells. In case IFNγ is essential to switch on suppressive 
activity of IAV-induced mono-MDSC in vivo, IFNγR+/+ but not IFNγR-/- mono-
MDSC isolated from the same mice should prevent T cell proliferation in vitro. 
This could help elucidating the role of IFNγ as trigger of suppression by 
mono-MDSC. Additionally, in order to analyze whether mono-MDSC indeed 
prevent T cell proliferation in vivo, a reasonable experiment would be to stain 
DISCUSSION 
 64 
lung slides from IAV-infected mice immunohistochemically for CD3, Ki-67 and 
iNOS. CD3+ T cells localizing close to iNOS producing cells should show no 
expression of Ki-67, which is a marker expressed in all mitotic phases of 
eukaryotic cells. In such an experiment, one could compare proliferation of T 
cells in situ in control mice and mice with blocked iNOS activity. 
As discussed above, the strategy to block iNOS expression in vivo via 
injection of a blocking anti-IFNγ antibody did not lead to changes in lung 
immunopathology. Interestingly, iNOS chemical or genetic blockade improves 
resistance of mice to lethal IAV doses, which led to the conclusion that 
excessive iNOS and NO are actually toxic and promote rather than prevent 
lung immunopathology in the IAV-infected lung [173-175]. In those studies, it 
was discussed whether production of NO, a highly toxic reactive nitrogen 
species, leads to destruction of delicate lung tissues. Therefore, iNOS-
producing mono-MDSC might not be essential for safeguarding lung tissues 
from T cell-induced immunopathology in IAV infection. However, mono-MDSC 
might play a role in formation of memory T cells. Following this line of 
thinking, iNOS expression by mono-MDSC might be responsible for avoiding 
massive proliferation of single clones of T cells infiltrating the lungs in the 
beginning of the T cell phase. This is also the period of time in which most 
mono-MDSC, IFNγ and iNOS are present in the infected lungs. Indeed, 
different groups claimed that IFNγ regulates memory T cell differentiation in T 
cell intrinsic but also extrinsic manners [176; 177]. More importantly, a recent 
report demonstrated that IFNγ acts limiting the memory T cell population size 
in IAV infection [178]. Therefore, it would be intriguing to test whether 
formation of memory T cell response is altered in IAV-infected mice in the 
absence of iNOS or mono-MDSC. This could unveil a new mechanism of 
regulation of memory T cells via the IFNγ/mono-MDSC/iNOS axis. 
In summary, monocytes were shown here to infiltrate the lungs of IAV-
infected mice and to develop into mono-MDSC, which show suppressive 
activity and hamper T cell proliferation in vitro. Therefore, this study provides 
evidence that MDSC can also appear during acute virus infection. 
Suppression activity was dependent on iNOS, the expression of which was 
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dependent on IFNγ in vivo. Although no enhanced lung immunopathology 
was observed upon IFNγ blockade in vivo, future studies might focus on the 
role of mono-MDSC in immunopathology under sterile/non-sterile conditions 
and in different organs as well as in regulating memory T cell response. 
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8. Conclusion and Outlook 
This study helped shedding light on different aspects of the immune system, 
with a strong focus on immune regulation. First, fundamental differences in 
the response of LN and spleen Tregs and Tnaïves after Treg depletion were 
observed. A mathematical model based on temporal high resolution data of 
Treg depletion and reconstitution as well as of Tnaïve homeostasis predicted 
that Treg homeostasis mechanisms quantitatively differ in LN and spleen. 
Differences in LN and spleen immune cells were then demonstrated also in 
other subsets such as DC, NK cells and B cells. Although further mechanistic 
studies are needed for drawing more conclusions, it seems clear that Tregs 
are directly or indirectly involved in keeping immune homeostasis of a range 
of different cells. Finally, the ability of monocytes to differentiate into mono-
MDSC upon IAV infection was evidenced, which led to suppression of a T cell 
response via iNOS production. This might lead to a reconsideration of the role 
of monocytes in this infection model and further studies might clarify the role 
of IFNγ/iNOS/mono-MDSC in regulating different types of inflammation in 
different organs and as well as in formation of memory T cells. Understanding 
immune regulation during IAV infection might lead to the ultimate goal of 
avoiding immune-mediated lung damage and associated death. 
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